Download Curriculum Vitae - University of Maryland School of Medicine

Curriculum Vitae
Jennifer K. (Kristie) Johnson, Ph.D., D (ABMM)
Associate Professor, Department of Pathology
University of Maryland School of Medicine
Date
October 7, 2016
Contact Information
Business Address:
Office Phone Number:
Laboratory Phone Number:
Fax:
Beeper:
Email:
Education
1992-1996
1996-2002
1998-2000
22 South Greene Street, Room N2W50B
Baltimore, Maryland 21201
(410) 328-6698
(410) 706-7062
(410) 706-8414
(410) 382-2337 x3977
[email protected]
B.S. Degree in Biology, minor in Chemistry, Salisbury State University
Salisbury, Maryland
Ph.D. in Microbiology and Immunology, University of Maryland, Baltimore
Thesis: Analysis of the Specificity and Genetics of Antibodies to Soman.
Mentor: David E. Lenz, Ph.D.
Rapid Transition Training Program, Categorical in Microbiology University of
Maryland School of Medicine
Department of Medical and Research Technology
Postgraduate Education and Training
2003-2006
Postdoctoral Fellowship, Department of Pathology, University of Maryland
School of Medicine
Mentor: Richard A. Venezia, Ph.D., D(ABMM)
Certifications
1998-Present Technologist in Microbiology, American Society of Clinical Pathology Board of
Certification
2010-Present Diplomate in Public Health and Medical Microbiology, The American Board of
Medical Microbiology of the American Academy of Microbiology
Employment History
Academic Appointments
2006-2012
Assistant Professor, Department of Pathology, University of Maryland School of
Medicine (Primary appointment)
2007-Present VA Research Health Scientist (WOC), Baltimore Veterans Administration
2011-2012
Assistant Professor, Department of Epidemiology and Public Health University of
Maryland School of Medicine (Secondary appointment)
JKJohnson
2012-Present Associate Professor, Department of Pathology, University of Maryland School of
Medicine (Primary appointment)
2012-Present Associate Professor, Department of Epidemiology and Public Health University
of Maryland School of Medicine (Secondary appointment)
2013-Present Associate Professor, Department of Microbiology and Immunology University of
Maryland School of Medicine (Secondary appointment)
Other Employment
1996-1997
ORISE Fellow, Toxicology Division, Toxicology Evaluation Branch
US Army Center for Health Promotion and Preventive Medicine
Aberdeen Proving Ground-Edgewood Area, Maryland 21010
1998
Graduate Research Assistant, Department of Oral and Craniofacial Sciences
School of Dentistry
University of Maryland, Baltimore
1998-2002
ORISE Fellow, Pharmacology Division, Biochemical Pharmacology Branch
US Army Medical Research Institute of Chemical Defense
Aberdeen Proving Ground-Edgewood Area, Maryland 21010
2003
Scientist - Section Head
Rapid Diagnostics: Bioterrorism Response Section
Maryland Department of Health and Mental Hygiene
Professional Society Memberships
1997-Present National and Maryland Branch of American Society of Microbiology
2006-Present Pan American Society of Clinical Virology
2008-Present Association of Molecular Pathology
2013-Present Society of Healthcare Epidemiology
Honors and Awards
1999
Excellence in Microbiology Award, University of Maryland School of Medicine
Department of Medical and Research Technology
2000-2001
Merit Scholarship Award, University of Maryland Dental School
2000-2002
NIH National Research Service Award Training Program
2011
Richard S. Schwalbe Award, American Society of Microbiology, Maryland
Branch
Clinical Activities
2006-2014
Associate Director of Clinical Microbiology and Virology Laboratories
Laboratories of Pathology, University of Maryland Medical Center
 Clinical Microbiology Seminar Series
 Pace Lectures for Laboratory Staff
 Physician Consults
 Patient Rounds
 Clinical Plate Rounds
 Member
o Pandemic Steering Committee
o Executive Infection Control Committee
Page 2
JKJohnson
o Antimicrobial Subcommittee
o Ebola Steering Committee
 Moved all protocols to electronic and placed on share drive for all
employees to view while working at the bench.
 Molecular Detection
o MRSA
o Influenza and RSV
o Respiratory viruses (10)
o Enterovirus
o Clostridium difficile
o PNA-FISH from positive blood cultures
 Surveillance
o MRSA
o Acinetobacter baumannii
o Carbapenem-Resistant Enterobacteriaceae
 Rapid Detection from Blood Cultures
 Antibiotic Resistance
o Fluconazole susceptibility in Candida species
o Carbapenemase detection in Enterobacteriaceae
2014-2015
Interim Director of Clinical Microbiology and Virology Laboratories.
Laboratories of Pathology, University of Maryland Medical Center
2014-2015
Interim Director of Clinical Microbiology, University of Maryland Pathology
Associates
2014-Present Co-Director of Bio-containment Unit, Laboratory, University of Maryland
Medical Center
2015-Present Director of Clinical Microbiology, University of Maryland Medical Center
2015-Present Director of Clinical Microbiology, University of Maryland Pathology Associates
Administrative Service
Institutional Service
2006-2014
Associate Director of Clinical Microbiology and Virology Laboratories
Laboratories of Pathology, University of Maryland Medical Center
2006-Present Member, UMMC Infection Control Executive Committee
2008-2010
Associate Member, Graduate Faculty
2009-Present Member, UMMC Pandemic Steering Committee
2010-Present Regular Member, Graduate Faculty
2011-Present Member, Host Defenses and Infectious Diseases Committee, University of
Maryland School of Medicine
2011-Present Interviewer, Office of Admissions, University of Maryland School of Medicine
2011-Present Member, UMMC Antimicrobial Subcommittee of the P&T Committee
2011-Present Member, Pathology Residency Committee
2011
Judge, Medical Student Research Day
2013-Present Member, Clinical Competency Committee, Department of Pathology
2014-2015
Interim Director of Clinical Microbiology and Virology Laboratories
Page 3
JKJohnson
2014-2015
2014-Present
2014-Present
2014-Present
2015-Present
2015-Present
2016-Present
2015-Present
2015-Present
Laboratories of Pathology, University of Maryland Medical Center
Interim Director of Clinical Microbiology, University of Maryland Pathology
Associates
Member, UMMC Strategic Steering Committee-Ebola Preparation Plan
Member, UMMC Laboratory Services Committee-Ebola Preparation Plan
Co-Director of Bio-containment Unit, Laboratory, University of Maryland
Medical Center
Member, Quality Assurance Oversight Committee, University of Maryland
Medical Center, Laboratories of Pathology
Member, Institutional BioSafety Committee, University of Maryland, Baltimore
Member, UMMC Laboratory Utilization Committee
Director of Clinical Microbiology, University of Maryland Medical Center
Director of Clinical Microbiology, University of Maryland Pathology Associates
Local Service
2009
Member of ASM Division C Chair nomination Committee
2010-2014
Judge for J. Howard Brown Award given by the Maryland Branch ASM
2010-Present Member, Maryland MDRO Collaborative
2011-2014
Board of Directors, American Society of Microbiology, Maryland Branch
2012-2013
President, American Society of Microbiology, Maryland Branch
National Service
2008-Present Reviewer, Diagnostic Microbiology and Infectious Diseases (1x/year)
2010-Present Reviewer, European Journal of Clinical Microbiology and Infectious
Diseases(1x/year)
2011-Present Reviewer, Journal of Medical Microbiology (1x/year)
2011-Present Reviewer, Journal of Clinical Microbiology (3x/year)
2011-Present Reviewer, Journal of Microbiological Methods (0-1x/year)
2011-Present Reviewer, American Journal of Infection Control (0-1x/year)
2012-Present Reviewer, PLOS ONE (2x/year)
2012-Present Member, Clinical Microbiology Mentoring Committee of the Professional
Practice Committee, American Society of Microbiology (Term until 2017)
2012-2014
Member, The American Board of Medical Microbiology (ABMM) Validation
Committee
2012
American Society of Microbiology Career Session (June 16, 2012)
2012-Present Reviewer, Infections (0-1x/year)
2012-Present Reviewer, Journal of Antimicrobial Chemotherapy (1x/year)
2014-Present American Society of Microbiology Division C Finance Committee
2014
Member, Expert Panel, UPMC Center for Health Security, Improving the Odds:
What government can do to encourage the development of commercially viable
infectious disease diagnostics.
2014-Present Member, The American Board of Medical Microbiology (ABMM) Item
Committee
2014
American Society of Microbiology Convener for Diagnostic Microbiology and
Epidemiology Session for the 114th General Meeting May 18, 2014: The Evolving
Page 4
JKJohnson
2014-Present
2015-Present
2015-Present
2016-Present
2016-Present
2016-Present
2016
2016
2016
2016-present
2016-present
Role on Active Surveillance for MDROs for Infection Prevention: The Impact of
New Landmark Studies upon the Clinical Microbiologist.
Reviewer, Annals of Clinical Microbiology and Antimicrobials (0-1x/year)
Member, Editorial Board, Journal of Clinical Microbiology (2017)
Member, Methods Application and Interpretation Working Group for the
Subcommittee on Antimicrobial Susceptibility Testing, Clinical Laboratory
Standards Institute (CLSI)
Member, Editorial Board, Journal of Applied Laboratory Medicine (2019)
Reviewer, Journal of Applied Laboratory Medicine (2x/year)
Member, Carbapenemase Inactivation Method Working Group, Clinical
laboratory Standards Institute (CLSI)
American Society of Microbiology Convener for Clinical Science and
Epidemiology Symposium for the ASM Microbe 2016 Meeting June 18, 2016:
Guess the Bacterial Resistance Mechanism
American Society of Microbiology Convener for Clinical Science and
Epidemiology Symposium for the ASM Microbe 2016 Meeting June 19, 2016:
Optimal Use of Rapid Diagnostics in the Clinical Microbiology Laboratory for
Quality Improvement and Clinical Care
Study Section Member, Defense Medical Research and Development Program
Scientific Lead, CDC/ASM Laboratory Medicine Best Practices committee on
Bloodstream Infections
Member, Association of Public Health Laboratories (APHL) Biosafety and
Biosecurity Partners Forum (recently appointed by SHEA)
Teaching Service
Prior to Faculty Appointment
1998
Laboratory Assistant, Pathogenic Microbiology,
3rd year Medical Technology Students- 6 contact hours/week
Department of Medical and Research Technology, University of Maryland School
of Medicine
1998
Lecturer
Pathogenic Microbiology
3rd year Medical Technology Students- 4 contact hours
Department of Medical and Research Technology, University of Maryland School
of Medicine
1999-2001
Laboratory Assistant
Dental Microbiology
2nd year Dental Students – 1 contact hour/week
University of Maryland Dental School
Faculty Appointment
Basic Sciences
2004-Present Preceptor, Laboratory Small Group
Host Defenses and Infectious Diseases Laboratory
Second year Medical Students
Page 5
JKJohnson
2005-2007
40 students/year, 6 hours/year
University of Maryland School of Medicine
Lecturer
Seminars in Biological Terrorism
Smallpox
6-8 students, 2 hours/year
Department of Pathology, University of Maryland School of Medicine
2006-Present Member of Thesis/Dissertation Committee
Department of Epidemiology and Preventive Medicine, University of Maryland
School of Medicine
7 graduate students, 20 hours/year per mentee
2007
Lecturer
Emerging Infections (NURS 418)
Molecular Epidemiology
20 nursing students, 2 hours/year
University of Maryland School of Nursing
2007-2013
Research Mentor
Molecular Epidemiology Practicum
Epidemiology Ph.D. Graduate Students
Molecular Epidemiology Track, University of Maryland Graduate School
2 students/ 20 hours
2009-Present Lecturer
Clinical Virology (MEDT 471)
15 students, 6 hours/year
Department of Medical and Research Technology, University of Maryland School
of Medicine
2009-Present Member of Thesis/Dissertation Committee
Department of Medical and Research Technology, University of Maryland School
of Medicine
1 graduate student, 20 hours/year per mentee
2010
Lecturer
Pathogenic Microbiology (MEDT 472)
12 students, 4 hours/year
Department of Medical and Research Technology, University of Maryland School
of Medicine
2010-Present Primary Mentor
Department of Epidemiology and Preventive Medicine, University of Maryland
School of Medicine
3 graduate students, 104 hours/year per mentee
2011-Present Lecturer, Bacteriology Laboratory I, II, and III
Host Defenses and Infectious Diseases Laboratory
Second year Medical Students
160 students/year, 6 hours/year
University of Maryland School of Medicine
Page 6
JKJohnson
2015-Present Lecturer, Principles of Pharmacology
University of Maryland, Baltimore
School of Medicine
Department of Pharmacology
10 graduate students, 6 hours/year
Clinical Sciences (Fellows and Residents)
2003-Present Medical Microbiology Plate Rounds
Clinical Microbiology Laboratory
1st and 2nd year Infectious Disease Fellows, 3rd or 4th year Medical Students,
Pathology Residents and Attendings
12-15 fellows per year, 2-3 medical students, 1 pathology resident, 1-2 faculty
members/year
78 contact hours/year
Department of Pathology, University of Maryland Medical Center
2006-Present Mentor
Medical Microbiology Rotations
5-6 pathology residents, 1-2 medical students
2 hours/ rotation
Microbiology Laboratory, University of Maryland Medical Center
2006-Present Medical Microbiology Lectures
Pathology Residents
10-12 residents, 8 contact hours
Department of Pathology, University of Maryland Medical Center
2014-Present Medical Microbiology Rotations
Infectious Disease Fellows
10-12 fellows/year, 10 contact hours
Department of Medicine, Division of Infectious Diseases, University of Maryland
Medical Center
Students/Residents/Fellows Mentored
*Indicates that I serve(d) as the primary mentor
Training
period
2006-2009
Student
Mentor
Current Position
Kristen Kriesel,
MS, Ph.D.
Ph.D. Student
Thesis Committee
Member
2007-2008
Kerri Thom, MD,
MS
Master Student
Thesis Committee
Member
STD MIS Data
Manager
Virginia State
Health Department
Assistant Professor,
University of
Maryland, School
of Medicine
Page 7
JKJohnson
2007
Simone Shurland,
Ph.D
Ph.D. Student
Laboratory Rotation
2007-2008
Simone Shurland,
Ph.D
Ph.D. Student
Thesis Committee
Member
Microbiologist,
FDA
Bethesda, Maryland
Microbiologist,
FDA
Bethesda, Maryland
2007-2009
Marin Schweizer,
Ph.D
Ph.D. Student
Thesis Committee
Member
Research Associate,
University of Iowa,
School of Medicine
2009
Albert Lee
Ph.D. Student
Laboratory Rotation
Ph.D. Student,
UMB
2009-2010
Anne Koehne de
Gonzalez
Medical Student
2009
Angela Stancil*
Master Student
Laboratory
Roatation
Pathology Resident,
Columbia
University Medical
Center, New York
City
Biology High
School Teacher
2009
Adebola Ajao
Ph.D. Student
Thesis Committee
Member
Microbiologist,
FDA
Bethesda, Maryland
2009
Monica Smith
Master Student
Thesis Committee
Member
Becton Dickinson
Sparks, MD
2009-2011
Angela Stancil*
Master Student
Thesis Committee
Member
Biology High
School Teacher
2010
Aaron Hess
Medical Student
2010
Jennifer Siu
2010
Marin Schweizer,
Ph.D.
Medical Student
Summer Rotation
Research Associate
2011-2012
Aaron Hess
Anesthesiology
Resident,
University of
Wisconsin-Madison
MD/MPH Student,
UMB
Research Associate,
University of Iowa,
School of Medicine
Anesthesiology
Resident,
University of
Wisconsin-Madison
MD/Ph.D. Student
Page 8
JKJohnson
2012-2012
Mallory Boutin*
Capstone Mentor
2011-2014
Postdoctoral Fellow
2012-2014
Tracy Hazen,
Ph.D.
Chris Pepin*
2013-2014
Shana Burrowes
2013-2014
Jackie Bork*
2015-2016
Emily Stucke
2015-2016
2016-Present
UM College Park
Bio-Engineering
Group
Eric Kong
2016-Present
Sarah Jackson
Ph.D. Student
Thesis Committee
Member
Ph.D. Student,
UMB
2016-Present
Natalia Blanco
Herrera, Ph.D.
Postdoctoral Fellow
Postdoctoral
Fellow, UMB
Student Laboratory
Rotation
Student Laboratory
Rotation
Research Elective
Student Laboratory
Rotation
Clinical Advisor,
Student Capstone
Project
Ph.D. Student
Thesis Committee
Member
Research Associate,
University of San
Diego
UMB Research
Associate
Ph.D. Student,
UMB
Ph.D. Student,
UMB
Clinical Instructor,
JHU
Ph.D. Student,
UMB
Bio-Engineering
Undergraduate
Students
Ph.D. Student,
UMB
Grant Support
Active Grants
10/01/11 - 03/31/17
(NCE)
07/01/12 - 12/31/17
(NCE)
04/01/14 - 03/31/16
Role: Co-Investigator (10%)
PI: M.C. Roghmann
“Metagenomic Studies of MRSA Colonization”
Veterans Health Administration CSR&D
Total Direct Costs: $508,781
Total Indirect Costs: $0
Direct laboratory work and personnel and review, interpret, analyze, and
publish data.
Role: Co-Investigator (10%)
PI: M.C. Roghmann
“Modifying Isolation Precautions for MRSA in Non-acute Care
Settings”
VA Merit Grant Health Services R&D
RII10-154
Total Direct Costs: $1,035,459
Total Indirect Costs: $0
Direct laboratory work and personnel and review, interpret, analyze, and
publish data.
Role: Co-Investigator (5%)
PI: K. Kotloff
Page 9
JKJohnson
(NCE)
08/01/15 - 07/31/19
09/30/15 - 12/29/16
9/15/15-9/14/17
09/30/15 - 09/29/18
10/01/15-3/31/18
03/01/16-02/28/18
“Incidence, Mode of Transmission, and Sequelae of Community-Acquired
Methicillin Resistant Staphylococcus aureus Infection in the Neonatal
Intensive Care Unit and the Effectiveness of Decolonization”
NIH VTEU
Direct Costs: $822,310
Direct laboratory work and personnel and review, interpret, analyze, and
publish data.
Role: Co-Investigator (5%)
PI: Thom
Removing barriers to hand hygiene and glove compliance: Evaluation of
two novel time-efficient interventions
Agency for Healthcare Research and Quality
R01 HS024108-01
Direct and Indirect cost: $1,571,807
Direct laboratory work and personnel and review, interpret, analyze, and
publish data.
Role: Principal Investigator (2%)
Sentinel Site Surveillance for AR Organisms II
CDC-SHEPheRD Program Contract RFTOP 2015-008
Direct Cost: $78,500
Indirect Cost: $20,500
Role: Co-investigator (10%)
PI: Cross
Development of a multivalent vaccine to prevent invasive infections and
colonization with Klebsiella pneumoniae and Pseudomonas aeruginosa.
Nosocimial Vaccine Company
Total Direct Costs: $3, 239,933
Provide bacterial strains and expertise in Klebsiella pneumoniae and
Pseudomonas aeruginosa.
Role: Co-investigator (10%)
PI: Harris
Epicenters for the Prevention of Healthcare Associated Infections (HAI) Cycle II
Centers for Disease Control
1U54CK0000450-01
Direct and Indirect cost: $1,432,368
Direct laboratory work and personnel and review, interpret, analyze, and
publish data.
Role: Co-investigator (10%)
PI: Harris
“Does Universal Glove and Gown use decrease carbapenem-resistance
Gram-negative bacteria”
AHRQ R18 HS024045
Total Directs: $770,800
Total Indirects: $417,310
Direct laboratory work and personnel and review, interpret, analyze, and
publish data.
Role: Co-Investigator (10%)
PI: M.C. Roghmann
“Transmission of Antibiotic-resistant Gram-negative Bacteria in Nursing
Homes.”
Page 10
JKJohnson
National Institute of Allergy and Infectious Diseases
R03-A1-122223
Total Direct Costs: $153,000
Direct laboratory work and personnel and review, interpret, analyze, and
publish data.
09/01/2016-08/31-17 Role: Principal Investigator (2%)
“Understanding the workflow of positive blood cultures from sampling to
results.”
Q-Linea
Direct Costs: $9,999
8/10/16-07/31/2020 Role: Co-Investigator (10%)
PI: Harris
“Epidemiology of CRE and MRSA transmission: patient and organism
factors”
NIH National Institute of Allergy and Infectious Diseases
1R01AL121146-01
Total Directs: $1,800,599
Direct laboratory work and personnel and review, interpret, analyze, and
publish data.
09/15/16-11/14/17
Role: Co-Principal Investigator (10%)
“Identification of Microbial disruption indices (MDI) predictive of
colonization and dominance by multi-drug resistant Pseudomonas
aeruginosa. “
Centers for Disease Control and Prevention
BAA 2016-N-17812
Total Costs: $459,721
Total Indirects: $606,837
Pending Grants
10/01/16-09/30/17
04/1/17-03/31/22
Completed Grants
09/01/05 - 07/31/12
Role: Principal Investigator (2%)
“A Clinical Evaluation of a Gastrointestinal Infection panel Assay system
(ACEGIS)”
Applied BioCode
Total Cost: $100,000
Role: Sub-award PI (10%)
PI: Bachman
“Integrated modeling of Klebsiella pneumoniae infections based on
bacterial genotype, patient factors and colonization status”
NIH R01 AI 125307 01 A1
NIH-DHHS-US
Total Cost: $312,770 sub award
Total Cost: $2,713,340
Role: Investigator/Scholar (75%) PI: A.R. Shuldiner
“Transmission of Plasmid Mediated AmpC β-lactamases”
University of Maryland Multidisciplinary Research Career Development
Program (MCRDP)
NIH K12RR023250
Page 11
JKJohnson
Total Direct Costs: $12,309,704
06/01/07 - 11/01/07 Role: PI (5%)
“Culture results for patients with positive blood cultures”
AdvanDx
Total Direct Costs: $3,000
08/01/07 - 07/31/08 Role: PI (75%)
“Understanding Resistance Mechanisms in Fecal Microorganisms”
University of Maryland GCRC
Total Direct Costs: $10,000
09/30/07 - 09/29/08 Role: Co-Investigator (in kind/mentor)
PI: K Kreisel
“Risk Factors and Outcomes of Infections Due to USA300 Methicillin
Resistant Staphylococcus aureus”
CDC R36 Grant for Public Health Research Dissertation
Program Announcement PAR-07-231
Total Direct Costs: $35,000
10/22/07 - 12/31/07 Role: PI (15%)
“BacLite for the detection of MRSA”
3M Medical Diagnostics
Total Direct Costs: $40,000
07/01/08 - 06/30/09 Role: Co-PI (5%)
PI: R. Venezia
“Detection of MRSA from Blood Cultures”
Microphage
Total Direct Costs: $21,000
02/01/10 - 02/01/11 Role: PI (5%)
“Clinical Validation of the Molecular-based BD GeneOhm VanR assay
for the presumptive identification of vancomycin resistant Enterococci in
perianal and/or rectal specimens”
Becton Dickinson
Total Direct Costs: $75,000
04/15/10 - 07/31/11 Role: Site PI (in kind/mentor)
PI: M. Schweizer
“Linezolid Therapy and Outcomes in Patients with Post-Influenza
Staphylococcus aureus Pneumonia, Controlling for Patient, Pathogen,
and Treatment Characteristics”
Pfizer
06/01/10 - 11/30/13 Role: Co-Investigator (5%)
PI: A.D. Harris
“Epidemiology of emerging pathogens among hospitalized patients”
2R01AI060859-05 Renewal
Direct Costs: $900,000
Indirect Costs: $436,500
Total Direct Costs: $100,000
06/28/10 - 12/01/11 Role: Co-Investigator (5%)
PI: K Thom
Maryland MDR Acinetobacter Prevalence Survey
3U50CI000485 Maryland Department of Health and Mental Hygiene
Direct Costs: $178,000
07/26/10 - 07/25/12 Role: Co-Investigator (5%)
PI: J. Furuno
Page 12
JKJohnson
08/16/10 - 08/14/13
03/01/11 - 02/28/15
08/01/11 - 07/31/14
10/01/11 - 09/30/12
01/31/12 - 02/01/14
08/01/12 - 07/31/13
08/01/12 - 07/31/14
12/10/12 - 07/31/14
“Using Nursing Home Antibiograms to Improve Antibiotic Prescribing
and Delivery”
AHRQ HHSA290200600020I
Direct Costs: $621,298
Role: Co-Investigator (5%)
PI: A.D. Harris
“Novel Interventions to Decrease Healthcare Associated Infections”
AHRQ (Choice)
Direct Costs: $1,064,827
Role: Co-Investigator (5%)
PI: M.C. Roghmann
“Human Microbiome and Healthcare-associated Infections”
National Institutes of Health, National Institute of Allergy and Infectious
Diseases
R01
Total Direct Costs: $1,134,557
Total Indirect Costs: $567,279
Role: Co-Investigator (10%)
PI: M.C. Roghmann
“Modifying Isolation Precautions for MRSA in Long Care Setting”
Agency for Healthcare Research and Quality
Total Direct Costs: $1,012,297
Total Indirect Costs: $338,262
Role: PI (no salary for PI)
“Drug Resistant Gram Negative Microorganisms in VA Long Term Care
Facilities”
Baltimore Research and Education Foundation, Inc.
Total Direct Cost: $19,500
Role: PI (10%)
“A novel agent to decrease contamination of hospital scrubs”
BioMed Protect Inc.
Total Direct Costs: $80, 845
Total Indirect Costs: $43, 252
The contract is with the UMB SOM Center for Clinical Trials.
Role: Principal Investigator (2%)
“Clinical Evaluation of the FilmArray Blood Culture Identification
System”
Idaho Technologies
Direct Costs: $90,451
Indirect Costs: $42,964
Role: Principal Investigator (10%)
“Development of a PCR Assay for the detection of MRSA”
Maryland Industrial Partnership (MIPS)
Direct Costs: $87, 948
Indirect costs: $16,468
Role: Principal Investigator (2%)
“Bacterial Identification and Susceptibility Reference Testing of Gramnegative Blood Culture Project”
Nanosphere
Page 13
JKJohnson
02/01/13 - 02/28/14
09/15/13 - 09/14/14
10/01/13 - 01/30/16
11/08/13 - 10/31/15
01/14/14 - 01/13/15
04/24/14 - 04/23/15
05/06/14 - 05/05/15
Direct Costs: $245,700
Indirect Costs: $105,300
Role: Co-Investigator of project (no salary support) PI: Fraser-Liggett
Contract/grant#: HHSN272200900009C
“Genome Sequencing Centers for Infectious Diseases”
Project Title: Comparative genomics and transcriptomics to identify
genetic mechanisms underlying the emergence of carbapenem resistant
Acinetobacter baumannii (CRAb)
National Institutes of Health/National Institute of Allergy and Infectious
Diseases
Role: Co-Investigator (10%)
PI: R Christenson
“Specimen Acquisition for Hepatitis Evaluations”
Roche
Direct Costs: $138,347.30
Indirect Costs: $35,970.30
Role: Principal Investigator (2%)
Sentinel Site Surveillance for AR Organisms
CDC-SHEPheRD Program Contract RFTOP 2013-001
Direct Cost: $78,500
Indirect Cost: $20,500
Role: Co-PI (10%)
PI: Harris, AD
“Risk factors for Pseudomonas on ICU admission and Prevalence of
antibiotic-resistant Pseudomonas on admission”
Cubist
Direct Costs: $110, 847.18
Indirect Costs: $27,711.80
Role: Principal Investigator (2%)
Verigene Gram-Negative Blood Culture Test: “Rapid identification of
Gram-negative Organisms and resistance in blood stream infections”
Nanosphere
Direct Costs: $28, 192
Indirect Costs: $8, 457.60
Role: Principal Investigator (2%)
“High Risk MDRO Gene Panel Beta Performance Evaluation”
OpGen
Direct Costs: $59,389
Indirect Costs: $17,817
Role: Principal Investigator (2%)
“Clinical Evaluation of the FilmArray Meningitis/Encephalitis Panel”
Bio-Fire Diagnostics
Direct Costs: $39,000
Indirect Costs: $11,700
Publications (Name change from Miller to Johnson in 2002)
Peer-reviewed journal articles
Page 14
JKJohnson
1. Miller, J.K., and D.E. Lenz. Development of an Immunoassay for Diagnosis of Exposure to
Toxic Organophosphourus Compounds. J. Appl. Toxicol. 2001. 21(S1):S23-S26.
PMID: 11920916
2. Johnson, J.K., D.M. Cerasoli, and D.E. Lenz. Role of Immunogen Design in Induction of
Soman-specific Monoclonal Antibodies. Immunology Letters. 2005. Immunology Letters 96(1);
121-127. PMID: 15585315
3. Chan-Tack K.M. and J.K. Johnson. Photo Quiz: An Unusual Gram Stain Finding. Clin.
Infect. Dis. 2005. 40(11); 1649 and 1677. PMID: 15895484
4. Jabra-Rizk M.A., J.K. Johnson, G.N. Forrest, K. Mankes, T.F. Meiller, R.A. Venezia.
Prevalence of Candida dubliniensis fungemia at a large teaching hospital.
Clin Infect Dis. 2005. Oct 1;41(7):1064-7 PMID: 16142677
5. Mehta S, J. Johnson, R.A. Venezia, G.N. Forrest. Emergence of linezolid-resistant
Enterococci in a neutropenic patient. J Hosp Infect. 2006. 62:125-7. PMID: 16099544
6. Furuno JP, J.C. McGregor, A.D. Harris, J.A. Johnson, J.K. Johnson, P. Langenberg, R.A.
Venezia, J. Finkelstein, D.L. Smith, S.M. Strauss, E.N. Perencevich. Identifying High-Risk
Groups for Carriage of Antibiotic-Resistant Bacteria. Arch Intern Med. 2006. 166:580-585.
PMID: 16534047
7. Johnson J.K., E.N. Perencevich, D.P. Lincalis, R.A. Venezia. Dog Bite Transmission of
Antibiotic Resistant Bacteria to a Human. Infect Control Hosp Epidemiol. 2006. 27:762-763.
PMID: 16807855
8. Forrest, G.N., S. Mehta, E. Weekes, D.P. Lincalis, J.K. Johnson, R.A. Venezia. Impact of
Rapid in-situ Hybridization Testing on Coagulase Negative Staphylococci positive Blood
Cultures. J Antimicro. Chemo. 2006. 58:154-158. PMID: 16636084
9. Forrest, G.N., K. Mankes, M.A Jabra-Rizk, E. Weekes, J.K. Johnson, D.P. Lincalis, R.A.
Venezia. Impact of PNA FISH of Candida albicans on antifungal therapy, mortality and costs.
J. Clin Microbiol. 2006. 44: 3381-3383. PMID: 16954279
10. Harris A.D., M. Kotetishvilli, S. Shurland, J.A. Johnson, J.G. Morris, J.K. Johnson. How
Important is Patient-to-Patient Transmission in Extended Spectrum β-Lactamase Escherichia
coli Acquisition. Am J Infect Control. 2007. 35: 97-101. PMID: 17327188
11. Wright, M.O., J.P. Furuno, RA Venezia, J.K. Johnson, H.C. Standiford, J.N. Hebden, J.
Hill, D.M. Hartley, A.D. Harris, E.N. Perencevich. Methicillin-resistant Staphylococcus aureus
among hospitalized prisoners. Infect Control Hosp Epidemiol. 2007. 28:877-879.
PMID: 17564994
12. Johnson, J.K., T. Khoie, S. Shurland, K. Kreisel, O.C. Stine, M.C. Roghmann. Skin and
Soft Tissue Infections from Methicillin-Resistant Staphylococcus aureus (MRSA) USA300
Clone. Emerg Infect Disease. 2007. 13:1195-1200. PMC: 2828080
13. Harris, A.D., E.N. Perencevich, J.K. Johnson, D.L. Patterson, J.G. Morris, S. Strauss, J. A.
Johnson. Patient-to-Patient Transmission is Important in Extended Spectrum beta-LactamaseProducing Klebsiella pneumoniae Acquisition. Clin Infect Dis. 2007. 45:1347-1350.
PMID: 17968833
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
14. Johnson, J.K., S.M. Arduino, O.C. Stine, J.A. Johnson, A.D. Harris. Multilocus Sequencing
Typing Compared to Pulsed-Field Gel Electrophoresis for Molecular Typing of Pseudomonas
aeruginosa. J. Clin Microbiol. 2007. 45:3707-3712. PMC: 2168506
Page 15
JKJohnson
15. Forrest, G.N, E. Weekes, J.K. Johnson. Increasing incidence of Candida parapsilosis
candidemia with echinocandin usage. J Infect. 2008. 56:126-129. PMID: 18082269
16. Riedel, D.J, J.K. Johnson, G.N. Forrest. Rhodotorula glutinis fungemia in a liver–kidney
transplant patient. Transplant Infectious Disease. 2008. 10:197-200. PMID: 17605726
17. Laurens, M.B., R.M. Becker, J.K. Johnson, J.S. Wolf, K.L. Kotloff. MRSA with
progression from otitis media and sphenoid sinusitis to clival osteomyelitis, pachymeningitis and
abducens nerve palsy in an immunocompetent 10 year-old patient. International Journal of
Pediatric Otorhinolaryngology 2008. 72:945-951. PMID: 18472169
18. Shepard, J.R., R.M. Addison, B.D. Alexander, P. Della-Latta, M. Gherna, G. Hall, G. Haase,
J.K. Johnson, W.G. Mer, H. Peltroche-Llacsahuanga, G.W. Procop, H. Stender, R. A. Venezia,
D. Wilson, F. Wu, M.J. Fiandaca. Multicenter Evaluation of the C. albicans/C. glabrata PNA
FISH method for Simultaneous Dual Color Identification of Candida albicans and Candida
glabrata Directly from Blood Culture Bottles. J. Clin Microbiol. 2008. 46: 50-55.
PMID: 17977998
19. Schweizer M.L., J.P. Furuno, A.D. Harris, J.C. McGregor, K.A. Thom, J.K. Johnson, M.D.
Shardell, E.N. Perencevich. Clinical Utility of Infection Control Documentation of Prior History
of Methicillin-resistant Staphylococcus aureus Colonization or Infection. Infect Control Hosp
Epidemiol. 2008.29:972-974. PMID: 18793097
20. Forrest, G.N., M.C. Roghmann, L.S. Toombs, J.K. Johnson, E. Weeks, D.P. Lincalis, R.A.
Venezia. PNA-FISH for Hospital Acquired Enterococcal Bacteremia: Delivering Earlier
Effective Antimicrobial Therapy. Antimicrob. Agents Chemother. 2008. 52:3558-63.
PMID: 18663022
21. Shurland, S. J.P. Furuno, R.A. Venezia, J.K. Johnson, M.C. Roghmann. Colonization Sites
of USA300 Methicillin-Resistant Staphylococcus aureus in Extended Care Residents. Infect
Control Hosp Epidemiol. 2009. 30: 313-318. PMID: 19239380
22. Johnson, J.K., G. Smith, M. S. Warren, R. A. Venezia, O. C. Stine, J. P. Nataro, W. Hsiao,
A. D. Harris. The Role of Patient-to-Patient Transmission in the Acquisition of Imipenemresistant Pseudomonas aeruginosa Colonization in the Intensive Care Unit. Journal of Infectious
Diseases. 2009. 200: 900-905. PMID: 19673646 Editorial by E. Laetenbach. Antimicrobial
Resistance in Gram-Negative Pathogens: Crafting the Tools Necessary to Navigate the Long
Ascent out of the Abyss. Journal of Infectious Diseases 2009. 200: 838-40. PMID: 19673645
23. Kreisel, K., M.C. Roghmann, M. Shardell, O.C. Stine, E.Perencevich, A.Lesse, F.Gordin, M.
Climo, J.K. Johnson. Assessment of the 48-Hour Rule for Identifying Community-Associated
Methicillin-Resistant Staphylococcus aureus Infections Complicated by Bacteremia. Infect
Control Hosp Epidemiol. 2010. 31(6); 657-9. PMID: 20412012
24. Morgan D., S. Liang, C. Smith, J.K. Johnson, A.D. Harris, J.P. Furuno, K.A. Thom, G.
Snyder, H. Day, E.N. Perencevich. Frequent Multidrug-resistant Acinetobacter baumannii
Contamination of Gloves, Gowns and Hands of Healthcare Workers. Infect Control Hosp
Epidemiol. 2010. 31(7); 716-21. PMID: 20486855
25. Kreisel, K., J.K. Johnson, O.C. Stine, M. Shardell, EN. Perencevich, A. Lesse, F. Gordin,
M. Climo, M.C. Roghmann. Illicit Drug Use and Risk for USA300 Methicillin-Resistant
Staphylococcus aureus Infections with Bacteremia. Emerg Infect Disease. 2010. 16(9)
(Medscape CME article) PMC: 3294968
26. Rasmussen, A.K.I., R.L. Skov, R.A. Venezia, J.K. Johnson, H. Stender. Evaluation of
mupA EVIGENE® assay for Determination of High-Level Mupirocin Resistance in
Staphylococcus aureus. J. Clin Microbiol. 2010. 48:4253-5. PMID: 20810775
Page 16
JKJohnson
27. Shurland S.M., O.C. Stine, R.A. Venezia, J.K. Johnson, M. Zhan, J.P. Furuno, R.R. Miller,
C. Pelser, M.C. Roghmann. Prolonged Colonization with USA300 MRSA in Extended Care
Residents. Infect Control Hosp Epidemiol. 2010. 38;838-41. PMID: 20569116
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
28. Thom K.A, W. Hsiao, A.D. Harris, O.C. Stine, D. Rasko, J.K. Johnson. Patients with
Acinetobacter baumannii bloodstream infection are colonized in the gastrointestinal tract with
the identical strains. Am J Infect Control, 2010. 38(9);751-3. PMID: 20570393
29. Harris, A.D., J.P. Furuno, M.C. Roghmann, J.K. Johnson, R. A. Venezia, H. C. Standiford,
M. L. Schweizer J. N. Hebden, E. N. Perencevich. Targeted surveillance of methicillin-resistant
Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicro Agents
Chemother. 2010. 54(8);3143-8. PMID: 20479207
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
30. Schweizer M.L., J.P. Furuno, A.D. Harris, J.K. Johnson, MD. Shardell, J.C. McGregor,
K.A. Thom, G. Sakoulas, E.N. Perencevich. Empiric Antibiotic Therapy for Staphylococcus
aureus Bacteremia May Not Reduce In-Hospital Mortality. PLoS ONE. 2010. 5(7);e11432.
PMID: 20625395
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
31. Morgan, D.J., H.R. Day, J.P. Furuno, A. Young, J.K. Johnson, D.D. Bradham, E.N.
Perencevich. Improving Efficiency in Active Surveillance for Methicillin-Resistant
Staphylococcus aureus or Vancomycin-Resistant Enterococcus at Hospital Admission. Infect
Control and Hosp Epidemiol. 2010. 31(12); 1230-1235. PMID: 21028966
32. Arnold R.S., K.A. Thom, S. Sharma, M. Phillips, J.K. Johnson, D.J. Morgan. Emergence of
Klebsiella pneumoniae Carbapenemase (KPC)-Producing Bacteria. South Med J. 2011.
10491:40-5. PMID: 21386985
33. Schweizer M.L., J.P. Furuno, G. Sakoulas, J.K. Johnson, A.D. Harris, M.D. Shardell, J.C.
McGregor, K.A. Thom, E.N. Perencevich. Increased Mortality with Accessory Gene Regulator
(agr)-Dysfunction in Staphylococcus aureus among Bacteremic Patients. Antimicrob Agents
Chemother. 2011. 55(3);1082-7. PMID: 21173172
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
34. Furuno J.P., S.M. Shurland, M. Zhan, J.K. Johnson, R.A. Venezia, A.D. Harris, M.C.
Roghmann. Comparison of the methicillin-resistant Staphylococcus aureus acquisition among
rehabilitation and nursing home residents. Infect Control and Hosp Epidemiol. 2011. 32(3); 2449. PMID: 21460509
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
35. Ajao A.O., A.D. Harris, M.C. Roghmann, J.K. Johnson, M. Zhan, J.C. McGregor, J.P.
Furuno. A Systematic Review of Measurement and Adjustment for Colonization Pressure in
Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci and Clostridium
difficile Acquisition Studies. Infect Control and Hosp Epidemiol. 2011. 32(5);481-9.
PMID: 21515979
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
Page 17
JKJohnson
36. Sahl J.W., J.K. Johnson, A.D. Harris, A.M. Phillippy, W.W. Hsiao, K.A. Thom, D.A.
Rasko. Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter
baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics.
2011. 12:291. PMID: 21639920
37. Harris A.D., J.K. Johnson, K.A. Thom, D.J. Morgan, J.C. McGregor, A.O. Ajao, A.C.
Moore, A.C. Comer, J.P. Furuno. Risk factors for Development of Intestinal Colonization with
Imipenem-resistant Pseudomonas aeruginosa in the Intensive Care Unit Setting. Infect Control
and Hosp Epidemiol. 2011. 32(7): 719-22. PMID: 21666406
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
38. Schweizer ML, Furuno JP, Harris AD, Johnson J.K., Shardell MD, McGregor JC, Thom
KA, Sakoulas G, Perencevich EN. Comparative effectiveness of nafcillin or cefazolin versus
vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infectious
Diseases. 2011. 11:279. PMID: 22011388
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
39. Roghmann M.C., J.K. Johnson, O.C. Stine, A. Lydecker, K. Ryan, B.D. Mitchell, A.R.
Shuldiner. Persistent Staphylococcus aureus colonization is not a strongly heritable trait in
Amish families. PLoS One. 2011. 6(2):e17368. PMID: 21386985
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
40. Kreisel, K.M., O.C. Stine, J.K. Johnson, E.N. Perencevich, M.D. Shardell, A.J. Lesse, F.M.
Gordin, M.W. Climo, M.C. Roghmann. USA300 Methicillin-Resistant Staphylococcus aureus
Bacteremia and the Risk of Severe Sepsis: Is USA300 MRSA Associated with More Severe
Infections? Diagn Microbiol Infect Dis. 2011. 70(3):285-90. PMID: 21558047
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
41. Ajao A.O., G. Robinson, M. Lee, T. Ranke, R.A. Venezia, J.P. Furuno, A.D. Harris, J.K.
Johnson. Comparison of Culture Media for Detection of Acinetobacter baumannii in
Surveillance Cultures of Critically-ill Patients. Eur J Clin Microbiol Infect Dis. 2011. 32(5);4819. PMID: 21487763
42. Thom K.A., J.K. Johnson, M. Lee, A.D. Harris. Environmental contamination because of
multidrug-resistant Acinetobacter baumannii surrounding colonized or infected patients. Am J
Infect Control. 2011. 39(9):711-5. PMID: 22041290
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
43. Furuno, J.P., J.K. Johnson, M.L. Schwizer, A. Uche, O.C. Stine, S.M. Shurland, G.N.
Forrest. Community-associated Methicillin-resistant Staphylococcus aureus Bacteremia and
Endocarditis among HIV Patients: a cohort study. BMC Infectious Diseases. 2011. Oct 31.
11;298. PMID: 22040268
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
44. Morgan DJ, Rogawski E, Thom KA, Johnson J.K., Perencevich EN, Shardell M, Leekha S,
Harris AD. Transfer of Multidrug-Resistant Bacteria to Healthcare Workers’ Gloves and Gowns
After Patient Contact Increases with Environmental Contamination. Crit Care Med. 2012. 40(4);
1045-51. PMID: 22202707
Page 18
JKJohnson
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
45. Hazen TH, G Robinson, AD Harris, DA Rasko, J.K. Johnson. Genome sequence of
Klebsiella oxytoca 11492-1, a nosocomial isolate possessing a FOX-5 AmpC β-lactamase. J.
Bacteriol. 2012. 194; 3028-29. PMID: 22582383
46. Thom KA, Howard T, Sembajwe S, Harris AD, Strassle P, Caffo BS, Carroll K, Johnson
J.K. Comparison of Swab versus Sponge Methodology for the Identification of Acinetobacter
baumannii from the Hospital Environment. J Clin Microbiol. 2012. 50 (6):2140.
PMID: 22461673
47. Robinson, G., AD Harris, DJ Morgan, L Pineles, B Belton, and J.K. Johnson And the
Benefits of Universal Gloving and Gowning (BUGG) Study group. Survival of MethicillinResistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) for
an extended period of transport. J Clin Microbiol, 2012. 50(7); 2466-68. PMID: 22535993
48. Ranke, T., AD Harris, P Strassle, and J.K. Johnson. The Recovery of Gram Negative
Bacilli in Stored Endotracheal Aspirate Samples. J Clin Microbiol, 2012. 60 (8); 2791-2.
PMID: 22649011
49. Thom KA, Maragakis LL, Richards K, Johnson J.K., Roup B, Lawson P, Harris AD, Fuss
EP, Pass MA, Blythe D, Perencevich EN, Wilson L. Assessing the Burden of Acinetobacter
baumannii in Maryland: A Statewide Cross-sectional Period Prevalence Survey. Infect Control
Hosp Epidemiol, 2012. 33(9); 883-888. PMID: 22869261
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
50. A.S. Hess, M. Shardell, J.K. Johnson, K.A. Thom, P. Strassle, G. Netzer, A.D. Harris.
Methods and recommendations for evaluating and reporting a new diagnostic test. Eur J Clin
Microbiol Infect Dis. 2012. 31 (9):2111-6. PMID: 22476385
51. Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, Johnson J.K.,
Nguyen C, Chen WH, Roghmann MC. Lower Antibody Levels to Staphylococcus aureus
Exotoxins are associated with Sepsis in Hospitalized Adults with Invasive Staphylococcus
aureus Infections. Journal of Infectious Diseases. 2012. 206 (6):915-23. PMID: 22807524
52. Strassle P, Thom KA, Johnson J.K., Leekha S, Lissauer M, Zhu J and Harris AD. The
effect of terminal contamination rates of multidrug-resistant Acinetobacter baumanii. Amer J
Infection Control. 2012. 40(10); 1005-7. PMID: 23199726
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
53. Ajao AO, Harris AD, Johnson J.K., Roghmann M, Perencevich EN, Schweizer ML, Zhan
M, Chen WH, Furuno JP. Association between Methicillin-resistant Staphylococcus aureus
Colonization and Infection May Not Differ by Age Group. Infect Control Hosp Epidemiol. 2013.
34; 93-95. PMID: 23221199
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
54. Ajao AO, Johnson J.K., Harris AD, Zhan M, McGregor JC, Thom KA, Furuno JP. Risk of
Acquiring Extended-Spectrum Beta-lactamase-Producing Klebsiella Species and Escherichia
coli from Prior Room Occupants in the Intensive Care Unit. Infect Control Hosp Epidemiol.
2013. 34: 453-458. PMID: 23571360
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
Page 19
JKJohnson
55. A.S. Hess, M. Shardell, J.K. Johnson, K.A. Thom, MC Roghmann, G. Netzer, DJ Morgan,
A.D. Harris. A Randomized Controlled Trial of Enhanced Cleaning to Reduce Contamination of
Healthcare Worker Gowns and Gloves with Multidrug-Resistant Bacteria. Infect Control Hosp
Epidemiol. 2013. 34: 453-458. PMID: 23571365
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
56. Rock C, Harris AD, Reich NG, Johnson J.K., Thom KA. Is hand hygiene before putting on
non-sterile gloves in the ICU a waste of healthcare worker time? A randomized controlled trial.
Am J Infect Control. 2013. 41(11): 994-6. PMID: 23891455
Directed laboratory work and personnel and reviewed, interpreted, analyzed, and
published data.
57. Harris AD, Pineles L, Belton B, Johnson J.K., Shardell M, Loeb M, Newhouse R, Dembry
L, Braun B, Perencevich EN, Hall KK, Morgan DJ and the Benefits of Universal Glove and
Gown (BUGG) Investigators. Universal Glove and Gown use and Acquisition of AntibioticResistant Bacteria in the ICU: A Randomized Trial. JAMA. 2013. 310 (15)1571-80.
PMID: 24097234
Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed,
and published data.
58. D.A.T. Shirley, E.L. Heil, J.K. Johnson. Ceftaroline Fosamil: A Brief Clinical Review.
Infectious Diseases and Therapy. 2013. 2(2):95-100. PMID: 25134474
59. Roghmann MC, Longinaker N, Croft L, Johnson J.K., Lydecker AD, Stine OC. Molecular
Epidemiology of Staphylococcus aureus colonization among the Older Order of Amish of
Lancaster, PA. Epidemiology and Infection 2014. 142(8):1722-6. PMID: 24230465
60. Johnson J.K., Wilson LE, Zhao L, Richars K, Thom KA, Harris AD. Point Prevalence of
Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae (KPCS) in Maryland.
Infect Control Hosp Epidemiol. 2014. 35(4):443-445. PMID: 24602955
61. Rock, C, Thom KA, Masnick M, Johnson J.K., Harris AD, Morgan DJ. Frequency of
Klebsiella pneumoniae Carbapenemase (KPC)-Producing and Non-KPC-Producing Klebsiella
Species Contamination of Healthcare Workers and the Environment. Infect Control Hosp
Epidemiol. 2014. 35(4):426-429. PMID: 24602950
Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed,
and published data.
62. Hazen TH, Zhao L, Sahl JW, Robinson GP, Harris AD, Rasko DA, Johnson J.K.
Characterization of Klebsiella sp. 10982, a colonizer of humans that contains novel antibiotic
resistance alleles and exhibits genetic similarities to plant and clinical Klebsiella isolates.
Antimicrob Agents Chemother. 2014. 58 (4):1879-88. PMID: 24395222
63. Hess AS, Kleinberg M, Sorkin JD, Netzer G, Johnson J.K., Shardell M, Thom KA, Harris
AD, Roghmann MC. Prior colonization is associated with increased risk of antibiotic-resistant
Gram-negative bacteremia in cancer patients. Diagn Microbiol Infect Dis. 2014. May;79;73-6.
PMID: 24582582
Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed,
and published data.
64. Hazen TH, Zhao L, Boutin MA, Stancil A, Robinson GP, Harris AD, Rasko DA, Johnson
J.K. Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli
and Klebsiella species isolated from ICU patients: the utility of whole genome sequencing in
healthcare settings. Antimicrob Agents Chemother. 2014. 58(8):4814-25. PMID: 24914121
Page 20
JKJohnson
65. Papp-Wallace, K., M. Winkler, J. Gatta, M. Taracila, S. Chilakala, Y. Xu, J. Johnson, R.
Bonomo. Reclaiming the efficacy of β-lactam-β-lactamase inhibitor combinations: avibactam
restores the susceptibility of ceftazidime against CMY-2 producing Escherichia coli. Antimicrob
Agents Chemother. 2014. 58(8): 4290-7. PMID: 24820081
66. Thom, KA, HC Standiford, J.K. Johnson, N Hanna, JP Furuno. Effectiveness of an
Antimicrobial Polymer to Decrease Contamination of Environmental Surfaces in the Clinical
Setting. Infect Control Hosp Epidemiol. 2014. 35(8): 1060-1062. PMID: 25026625
Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed,
and published data.
67. Furuno JP, Comer AC, Johnson J.K., Rosenberg JH, Moore SL, MacKenzie TD, Hall KK,
Hirshon JM. Using Antibiograms to Improve Antibiotic Prescribing in Skilled Nursing Facilities.
Infect Control Hosp Epidemiol. 35:S3:S56-S61. PMID: 25222899
Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed,
and published data.
68. Boutin, MA, KA Thom, M Zhan, J.K. Johnson. A Randomized-crossover trial to decrease
bacterial contamination on hospital scrubs. Infect Control Hosp Epidemiol. 2014. 35(11):14111413. PMID: 25333437
69. J Bork, W Wilding, CW Claassen, J.K. Johnson, M. Kleinberg. Photo Quiz: Fungal
Sinusitis in a 75-Year-Old Neutropenic Cancer Patient. Clinical Infectious Diseases. Clin Infect
Dis. 2015. Jan 15;60(2):274. Answer 321-2. PMID: 25538223
70. J Bork, S Leekha, E Heil, L Zhao, R Badoamas, J.K. Johnson. Rapid Testing Using
Verigene Gram-Negative Blood Culture Nucleic Acid Test with Combination with Antimicrobial
Stewardship Intervention Against Gram-Negative Bacteremia. Antimicrob Agents Chemother.
2015. Mar;59(3):1588-95. PMID: 25547353
71. Rock C, Harris AD, Johnson J.K., Bischoff WE. Thom KA. Infrequent Air Contamination
with Acinetobacter baumannii of Air Surrounding Known Colonized or Infected Patients. Infect
Control Hosp Epidemiol. 2015. 36(7):830-2. PMID: 25825865
Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed,
and published data.
72. Roghmann MC, J.K. Johnson, JD Sorkin, P Langenberg, A Lydecker, B Sorace, L Levy, L
Mody. Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA) to Healthcare
Worker Gowns and Gloves During Care of Nursing Home Residents. Infect Control Hosp
Epidemiol. 2015. 36(9):1050-7. PMID: 26008727
Directed laboratory work for 20 sites and personnel and reviewed, interpreted, analyzed,
and published data.
73. Hines MC, T AL-Salamah, EL Heil, H Mallemat, M Witting, J.K. Johnson, M Winters, BD
Hayes. Resistance patterns of Escherichia coli in women with uncomplicated urinary tract
infection do not correlate with Emergency Department antibiogram. Journal of Emerg Med.
2015. 49(6):998-1003. PMID: 26281821
74. McDanel JS, Perencevich EN, Diekema DJ, Winokur PL, Johnson J.K., Herwaldt LA,
Smith TC, Chrischilles EA, Dawson JD, Schweizer ML. Association between microbial
characteristics and poor outcomes among patients with methicillin-resistant Staphylococcus
aureus pneumonia: a retrospective cohort study. Antimicrob Resist Infect Control. 2015. 4:51.
PMID: 26668737
Page 21
JKJohnson
75. Morgan, DJ, S Leekha, L Croft, CA Burnham J.K. Johnson, L Pineles, AD Harris, ER
Dubberke. The Importance of Colonization with Clostridium difficile on Infection and
Transmission. Curr. Infect Dis Rep. 2015. 17(9): 499. PMID: 26239132
76. Epstein L, J Edwards, AL Halpin, MA Preas, D Blythe, AD Harris, D Hunt, J.K. Johnson,
M Filippell, CV Gould, S Leekha. Evaluation of a Novel Intervention to Reduce Unnecessary
Urine Cultures in Intensive Care Units at a Tertiary Care Hospital, Maryland 2011-2014 Infect
Control Hosp Epidemiol. 2016. 37(5):544-8. PMID: 26832608
77. Sarg M, G Waldrop, M Beier, EL Heil, KA Thom, MA Preas, J.K. Johnson, AD Harris, S
Leekha. Impact of Changes in Urine Culture Ordering Practice on Antimicrobial Utilization in
Intensive Care Units at an Academic Medical Center Infect Control Hosp Epidemiol. 2016.
37:448-454. PMID: 26778179
78. Harris AD, SS Jackson, G Robinson, L Pineles, S Leekha, KA Thom, M Doll, MM
Pettigrew and J.K. Johnson. Pseudomonas aeruginosa colonization n the ICU: Prevalence, risk
factors and clinical outcomes. Infect Control Hosp Epidemiol. 2016. 37(5):544-8. PMID:
26832307
79. OC Stine, S Burrowes, S David, J.K. Johnson, MC Roghmann. Transmission Clusters of
Methicillin-Resistant Staphylococcus aureus in Long-Term Care Facilities Based on WholeGenome Sequencing. Infect Control Hosp Epidemiol. 2016. 37(6):685-91. PMID: 26941060
80. RG D’Angelo, J.K. Johnson, JT Bork, EL Heil. Treatment options for extended-spectrum
beta-lactamase (ESBL) and AmpC-producing bacteria. Expert Opin Pharmacother. 2016. 17
(7):953-67. PMID: 26891857
81. McDanel JS, Perencevich EN, Storm J, Diekema DJ, Herwaldt L, Johnson J.K., Winokur
PL, Schweizer ML. Increased Mortality Rates Associated with Staphylococcus aureus and
Influenza Co-infection, Maryland and Iowa, USA. Emerg Infect Dis. 2016. 22(7):1253-6.
PMID: 27315549
82. Salimnia H, Fairfax MR, Lephart PR, Schreckenberger P, DesJarlais SM, Johnson J.K.,
Robinson G, Carroll KC, Greer A, Morgan M, Chan R, Loeffelholz M, Valencia-Shelton F,
Jenkins S, Schuetz AN, Daly JA, Barney T, Hemmert A, Kanack KJ. Evaluation of the
FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial. J Clin
Microbiol. 2016. 54(3):687-98. PMID: 26739158
83. Wiener ES, E Heil, LM Hynicka, J.K. Johnson. Are Fluoroquinolones Appropriate for the
Treatment of Extended-Spectrum Beta-Lactamase-Producing Gram-Negative Bacilli? Journal of
Pharmacy Technology. 2016. 32:16-21.
84. Heil E and J.K. Johnson. Impact of CLSI Breakpoint Changes on Microbiology
Laboratories and Antimicrobial Stewardship Programs. 2016. J Clin Microbiol. 54(4):840-4.
PMID: 26791363
85. Pettigrew MM, J.K. Johnson, AD Harris. The human microbiota: Novel targets for
hospital-acquired infections and antibiotic resistance. Ann Epidemiol. 2016. 26(5):342-7.
PMID: 26994507
86. Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, Lephart P, Salimnia H,
Schreckenberger PC, DesJarlais S, Reed SL, Chapin KC, LeBlanc L, Johnson J.K., Soliven NL,
Carroll K, Miller JA, Dien Bard J, Mestas J, Bankowski M, Enomoto T, Hemmert AC, Bourzac
K. Multicenter Evaluation of the BioFire FilmArray Meningitis Encephalitis Panel for the
Detection of Bacteria, Viruses and Yeast in Cerebrospinal Fluid Specimens. J Clin Microbiol.
2016. [Epub ahead of print]. PMID: 27335149
Page 22
JKJohnson
87. Wallace L, SC Daugherty, S Nagaraj, JK Johnson, AD Harris, DA Rasko. The use of
comparative genomics to characterize the diversity of Acinetobacter baumannii surveillance
isolates in a health care institution. Antimicrob Agents Chemother. 2016. (Epub ahead of
prient). PMID: 27458211
88. JK Johnson, GL Robinson, L Zhao, AD Harris, OC Stine, KA Thom. Comparison of
molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients.
Diagn Microbiol Infect Dis. 2016. (accepted).
89. E Kong, JK Johnson, MA Jabra-Rizk. Community Associated methicillin-resistant
Stapylococcus aureus: An Enemy Amidst Us. PLOS Pathogens. 2016. (accepted)
90. G Kumarachandran, JK Johnson, E Graffunder, DA Shirley, EL Heil. Predictors of adverse
outcomes in children with Staphylococcus aureus bacteremia. Journal of Pediatric
Pharmacology and Therapeutic. 2016. (accepted)
Non-peer reviewed journal articles
1. Johnson, J.K. and D. Cashara. 2013. Current Rapid Screening Methods for Gastrointestinal
Colonization of Vancomycin Resistant Enterococci (VRE). Clinical Microbiology
Newsletter. 35(6);46-51. Available at:
http://www.sciencedirect.com/science/article/pii/S019643991300010X
2. Hirshon JM, Comer AC, Rosenberg JH, Johnson J.K., Moore SL, MacKenzie TD, Hall KK,
Furuno JP. Methodological Challenges Associated with Developing and Implementing
Antibiograms in Nursing Homes. Advances in the Prevention and Control of HAIs. June
2014. Agency for Healthcare Research and Quality, Rockville, MD. Available at:
http://www.ahrq.gov/professionals/quality-patient-safety/patient-safetyresources/resources/advances-in-hai/hai-article9.html
Abstracts
1. Miller, J.K., and D.E. Lenz. Development of an Immunoassay for Diagnosis of Exposure to
Toxic Organophosphourous Compounds. 1998. (Proceeding of the 1998 Medical Defense
Bioscience Review, Hunt Valley, MD)
2. Miller, J.K., D.M. Cerasoli, A.A. Brimfield and D.E. Lenz. A Model System For Examining
the Role of Epitope Structure in Determining Monoclonal Antibody Specificity. 1999. Fed Proc
13(4), A333. (Abstract number 258.9)
3. Cerasoli, D.M., J.K. Miller, J.J. Schlager, J.H. Clark, R. Morlarty, A.A. Brimfield, and D.E.
Lenz. Binding Properties of Antibodies Raised Against Structurally Different Transition State
Analog Immunogens. 1999. Fed Proc 13(4), A333. (Abstract number 258.10).
4. Miller, J.K., D.M. Cerasoli, and D.E. Lenz. Characterization of Antibodies Toward a
Biologically Active Hapten. 2000. FASEB Journal 14 (6), A956. (Abstract number 44.6)
5. Miller, J.K., D.M. Cerasoli, A.C. Buenafe, MB Rittenberg, and D.E. Lenz. Sequence
Differences in Light Chain Genes Affect the Binding Specificity of Anti-hapten Antibodies.
2001. FASEB J. 15 (4): A339 (Abstract number 274.4)
6. Wright M.O., Venezia R.A., Johnson J.K., Furuno J.P., Standiford H.C., Hebden J.N., Hill
J.H., and Perencevich E.N. Methicillin-resistant Staphylococcus aureus (MRSA) among
hospitalized patients transferred from correctional facilities (CF): the Maryland Experience.
2004. Interscience Conference on Antimicrobial Agents and Chemotherapy 44:378. (Abstract K1856)
Page 23
JKJohnson
7. Furuno J.P., McGregor J.C., Harris A.D., Johnson J.A., Johnson J.K., Langenberg P.,
Venezia R.A., Finkelstein J., Smith D.L., Perencevich E.N. Identifying Patients at High Risk for
Colonization by Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant
Enterococci upon Hospital Admission: Use of a Clinical Prediction Rule. 15th Annual Scientific
Meeting of the Society for Healthcare Epidemiology of America. April 2005. Los Angeles, CA.
8. Rizk, M.A., J.K. Johnson, M. Shirtliff, K.M. Oliveira, K. Haverkos, T.F. Meiller. PNA
FISH Analysis of Microbial Biofilms. American Society of Microbiology 105th General Meeting.
June 2005. Atlanta, GA. (Abstract J-018)
9. Rizk, M.A., M.E. Shirtliff, J.K. Johnson, S.J. Arley, T.F. Meiller. Effect of Farnesol on
Mixed Species Biofilm. American Society of Microbiology 105th General Meeting. June 2005.
Atlanta, GA. (Abstract J-018)
10. Rizk, M.A., J.K. Johnson, K. Mankes, G. Forrest, T.F. Meiller, R.A. Venezia. Candida
dubliniensis Fungemia. American Society of Microbiology 105th General Meeting. June 2005.
Atlanta, GA. (Abstract F-019)
11. Mankes, K., G.N. Forrest, M.A. Jabra-Rizk, J.K. Johnson, R.A. Venezia. Outcomes of
Peptide Nucleic Acid Fluorescence in situ Hybridization Probes for Rapid Identification of
Candida albicans. 43rd IDSA Meeting. October 2005. San Francisco. (Abstract 276)
12. Thom, K., K. Mankes, G. Forrest, M. Rizk, M. Caplan, J. Johnson, R.A. Venezia. A
Treatment Algorithm Using Rapid Diagnosis of Candidemia with Fluconazole Susceptibility
Testing. Interscience Conference on Antimicrobials and Chemotherapy 45th Meeting. December
2005. Washington, D.C. (Abstract O-179)
13. Johnson, J.K., A.A. Roberts, G.N. Forrest, D.P. Lincalis, R.A. Venezia. Rapid
Identification of Enterococcus species in Positive Blood Cultures with Therapeutic Implications.
American Society of Microbiology 106th General Meeting. May 2006. Orlando, Florida.
(Abstract C-147)
14. Roghmann, M.C., T. Khoie, S. Shurland, K. Kreisel, J.K. Johnson, A. Feller, E. Tai, O.C.
Stine, J.A. Johnson, D. Jerrard and J. Flanagan. Increase in Skin and Soft Tissue Infections
associated with an Increase in Community-associated Methicillin Resistant S. aureus Infections.
Veterans Administration Research Day. May 2006. Baltimore, Maryland.
15. Shurland, S., J.K. Johnson, K. Kreisel, O. C. Stine, R. A. Venezia, M. C. Roghmann.
Pulsed Field Type USA300 MRSA is Endemic in a Long-Term Care Unit. At the 46th annual
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco,
CA September 29, 2006. (Slide Presentation).
16. Johnson, J.K., K. Stellrecht, M. Roghmann, R.A. Venezia. Comparison of Real-time PCR
to Culture for Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) in a Long
Term Care Unit. 46th annual Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC). September 2006. San Francisco, CA. (Abstract D-0840)
17. Harris, A.D., M. Kotetishivili, S. Shurland, J.A. Johnson , J.G. Morris Jr., L. Nemoy, J.K.
Johnson. Importance of Patient-to-Patient Transmission in Extended Spectrum β-Lactamase
(ESBL) Escherichia coli Acquisition. 46th annual Interscience Conference on Antimicrobial
Agents and Chemotherapy (ICAAC). September 2006. San Francisco, CA. (Abstract)
18. Yeung, S., E. Weekes, G. Forrest, J.K. Johnson, R.A. Venezia. Clinical Efficacy of Using
Vancomycin MICs for Treating Methicillin Resistant Staphylococcus aureus Bacteremia. 44th
Annual Meeting of the Infectious Disease Society of America. October 2006. Toronto, Ontario,
Canada.
Page 24
JKJohnson
19. Forrest, G., E. Weekes, M.A. Rizk, D. Lincalis, J.K. Johnson, R.A. Venezia. Effectiveness
of a Treatment Algorithm for Candidemia Using Rapid Diagnosis. 44th Annual Meeting of the
Infectious Disease Society of America. October 2006. Toronto, Ontario, Canada.
20. Lane, S., R.A. Venezia, J.K. Johnson, G. Forrest. Increasing Resistance to Vancomycin and
Daptomycin in MRSA Isolates. 44th Annual Meeting of the Infectious Disease Society of
America. October 2006. Toronto, Ontario, Canada.
21. Weekes, E., G. Forrest, D. Lincalis, J.K. Johnson, R.A. Venezia. Impact of Peptide Nucleic
Acid (PNA) Fluorescence in situ Hybridization (FISH) for Enterococcal blood stream infections.
44th Annual Meeting of the Infectious Disease Society of America. October 2006. Toronto,
Ontario, Canada.
22. Wu, F., P. Della-Latta, R. Addison, B. Alexander, G. Procop, D. Wilson, W. Merz, M.
Gherna, J.K. Johnson, A. Roberts, J.R. Shepard, M. J. Fiandaca. Dual Color PNA FISH Assay
for Simultaneous Identification of Candida albicans and Candida glabrata Directly from
Positive Blood Culture Bottles. 44th Annual Meeting of the Infectious Disease Society of
America. October 2006. Toronto, Ontario, Canada.
23. Roghmann M, K. Uduhiri, M. Davis, S. Shurland, M. Zhan, R.A. Venezia, J.K. Johnson.
Acquisition of MRSA Colonization in Extended Care Facilities. Society for Healthcare
Epidemiology of American (SHEA) National Meeting. April 2007. Baltimore, Maryland.
24. Johnson T, J.K. Johnson, R.A. Venezia, S. Shurland, M. Roghmann. Culture Rules for the
Discontinuation of Methicillin-Resistant Staphylococcus aureus (MRSA) Contact Precautions in
Extended Care Facilities. Society for Healthcare Epidemiology of American (SHEA) National
Meeting. April 2007. Baltimore, Maryland.
25. Harris, A.D., E.N. Perencevich, J.K. Johnson, D.L. Paterson, J.G. Morris, S. Strauss, J.A.
Johnson. Patient-to-Patient Transmission is Important in Extended Spectrum beta-LactamaseProducing Klebsiella pneumoniae Acquisition. Society for Healthcare Epidemiology of
American (SHEA) National Meeting. April 2007. Baltimore, Maryland.
26. Poulter, M.D., S.I. Getchell-White, G.L. Smith, D.C. Dirks, J.L. Carroll, J.C. Tartaglino,
J.K. Johnson. Evaluation of BioRad MRSA SelectTM Chromogenic Agar for Detection of
Methicillin Resistant Staphylococcus aureus in Surveillance Samples. American Society of
Microbiology 107th General Meeting. May 2007. Toronto, Ontario, Canada.
27. Shurland, S., J.K. Johnson, R. A. Venezia, O. C. Stine, M. Roghmann. Screening for
USA300 MRSA: Are the Anterior Nares Adequate? Interscience Conference on Antimicrobials
and Chemotherapy 47th Meeting. September 2007. Chicago, Illinois. (Abstract K-448)
28. Standiford, H., J. Hebden, M. Algire, R.A. Venezia, J.K. Johnson. Early Impact of an
Extensive Methicillin Resistant Staphylococcus aureus (MRSA) Eradiation Program at an
Academic Medical Center on Hospital Acquired MRSA Bacteremia. Interscience Conference on
Antimicrobials and Chemotherapy 47th Meeting. September 2007. Chicago, Illinois. (Abstract K459)
29. Veneiza, R.A., M.D. Poulter, G.L. Smith, J.K. Johnson. The Detection of Methicillin
Resistant Staphylococcus aureus (MRSA) in Surveillance Samples by a Chromogenic Agar and
PCR. Interscience Conference on Antimicrobials and Chemotherapy 47th Meeting. September
2007. Chicago, Illinois. (Abstract D-875)
30. Kreisel, K., Johnson, J.K., Shardell, M., Perencevich, E., Stine, O.C., Roghmann, M. Are
people with USA300 MRSA BSI more likely to die? SHEA, Orlando, FL, April 2008.
Page 25
JKJohnson
31. A.C. Moore, J.P. Furuno, E.N. Perencevich, T.J. Babineau, M.C. Roghmann, J.K. Johnson,
R.A. Venezia, HC. Standiford, J.N. Hebdon, A.D. Harris. Early Lessons on Targeted Whole
Hospital Active Surveillance. SHEA, Orlando, FL, April 2008.
32. Venezia, R.A., G. Smith, M.S. Warren, J.K. Johnson. Detection of high level murpirocin in
Staphylococcus aureus with molecular probe assay for mupA. American Society of Microbiology
108th General Meeting. May 2008. Boston, MA. (Abstract C-001)
33. Johnson, J.K., R.A Venezia, O.C. Stine, M.S. Warren, A.D. Harris. Are isolates from
patients who acquire colonization with imipenem-resistant Pseudomonas aeruginosa and had a
previous susceptible strain clonal? At the joint 48th annual Interscience Conference on
Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of
America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation).
34. Johnson, J.K., G. Smith, R.A Veneiza, S.M. Strauss, A.C. Moore, A.D. Harris. Patient-toPatient Transmission of Imipenem-Resistant Pseudomonas aeruginosa in the Intensive Care
Unit. At the joint 48th annual Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific Meeting,
Washington DC, October 27, 2008. (Poster Presentation)
35. Schweizer ML, Sakoulas G, Furuno JP, Johnson J.K., Harris AD, Thom KA, Morgan DJ,
Perencevich EP. Increased Mortality with Loss of Function of the accessory gene regulator (agr)
in Staphylococcus aureus Bacteremia. At the joint 48th annual Interscience Conference on
Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of
America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation).
36. Roghmann M, Shurland SM, Furuno JP, Perencevich EN, Harris AD, Venezia RA, Stine
OC, Johnson J.K.. Higher levels of nasal colonization with Methicillin-resistant S. aureus
(MRSA) is associated with MRSA Transmission to the Environment in Extended Care
Residents. At the joint 48th annual Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific Meeting,
Washington DC, October 27, 2008. (Poster Presentation).
37. Thom KA, Standiford HC, Johnson J.K., Strauss SM, Hanna N, Goatee C, Furuno JP.
Impact of Antimicrobial Treatment of Environmental Surfaces on Contamination by Important
Nosocomial Bacteria. At the joint 48th annual Interscience Conference on Antimicrobial Agents
and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of America Scientific
Meeting, Washington DC, October 27, 2008. (Poster Presentation).
38. Forrest, G.M., M.E. Kent, J.K. Johnson, R.A. Venezia. Evaluation of the Candida
albicans/C. glabrata (CAG) Peptide Nucleic Acid Fluorescence in Situ Hybridization (PNA
FISH) Test on Patient Management. At the joint 48th annual Interscience Conference on
Antimicrobial Agents and Chemotherapy (ICAAC)/46th annual Infectious Disease Society of
America Scientific Meeting, Washington DC, October 27, 2008. (Poster Presentation).
39. Kreisel, K., A. Lesse, F. Gordin, M. Climo, J.K. Johnson, M. Shardell, E. Perencevich,
O.C. Stine, M. Roghmann. Is USA300 MRSA BSI Associated with Increased Mortality? 19th
Annual Scientific meeting of the Society for Healthcare Epidemiology of America, San Diego,
CA, March 20, 2009.
40. Smith C.L, S.Y. Liang, D.J. Morgan, J.K. Johnson, J. P. Furuno, K.A. Thom, G.N. Snyder,
A.D. Harris, E.N. PerencevichN. Contamination of healthcare workers’ gowns and gloves with
multidrug-resistant Acinetobacter baumannii occurs frequently after patient contact. (Oral
Presentation, # 276). 19th Annual Scientific meeting of the Society for Healthcare Epidemiology
of America, San Diego, CA, March 20, 2009.
Page 26
JKJohnson
41. Johnson, J.K., W. Hsiao, K. Thom, O. C. Stine, A.D. Harris. Patients with Acinetobacter
baumannii Bacteremia are Colonized with Identical Strains.19th Annual Scientific meeting of
the Society for Healthcare Epidemiology of America, San Diego, CA, March 20, 2009.
42. Schweizer M.L., J.P. Furuno, J.K. Johnson, A.D.Harris, G. Sakoulas, D.J. Morgan, E.N.
Perencevich. Increased Vancomycin, Daptomycin and Linezolid Minimum Inhibitory
Concentrations (MIC) are Not Associated with Higher Mortality Among Patients with
Staphylococcus aureus Bacteremia. Poster Presentation (Presentation # 227). 19th Annual
Scientific meeting of the Society for Healthcare Epidemiology of America, San Diego, CA,
March 20, 2009.
43. Lincalis, D., R.A. Venezia, J.K. Johnson. PNA FISH S. aureus Procedure Modification
Decreases Turn Around Time. American Society of Microbiology 109th General Meeting. May
2009. Philadelphia, PA. (Accepted)
44. Hsiao, W.L., J.K. Johnson, K. Thom, R. Riley, O. C. Stine, A. D. Harris. Patients with
Acinetobacter baumannii Bacteremia are Colonized with Identical Strains. American Society of
Microbiology 109th General Meeting. May 2009. Philadelphia, PA. (Accepted)
45. Kingery, J.D., P.D. Stamper, L.R. Peterson, E.A. Usacheva, J.K. Johnson, R.A. Venezia,
M. Grayson, D. Manandhar, M. Mehta, P. Patel, S. Paule, G. Smith, M. Warren, K.C. Carroll. A
Novel Phage Technology for the Detection of S. aureus and differentiation of MSSA and MRSA
in Positive Blood Culture Bottles. American Society of Microbiology 109th General Meeting.
May 2009. Philadelphia, PA.
46. Johnson, J.K., G. Smith, C.R. Bethel, R.A. Venezia, R.A. Bonono, J.P. Nataro, O.C. Stine,
A. D. Harris. Defining Transmission Dynamics among Escherichia coli and Klebsiella spp
Possessing Amp C β-lactamases. 49th annual Interscience Conference on Antimicrobial Agents
and Chemotherapy (ICAAC). September 2009. San Francisco, CA.
47. Forrest, G., J.K. Johnson, R.A. Venezia. Sustained Effect of Peptide Nucleic Acid
Fluorescent in-situ Hybridization (PNA-FISH) on Antimicrobial Utilization and Costs. 49th
annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
September 2009. San Francisco, CA.
48. Schweizer M., J.P. Furuno, A.D. Harris, J.K. Johnson, M. Shardell, J. McGregor, K.A.
Thom, E.N. Perencevich. Nafcillin or 1st Generation Cephalosporins (Naf/ceph1) are Superior
Antibiotics for the Treatment of Methicillin-susceptible S. aureus (MSSA) Bacteremia. 49th
annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
September 2009. San Francisco, CA. (Oral Presentation)
49. Thom K.A., J.K. Johnson, M.S. Lee, A. Lee, A.D. Harris. Multidrug-resistant
Acinetobacter baumannii is frequently found on Environmental Surfaces surrounding Colonized
or Infected Patients. Fifth Decennial International Conference on Healthcare-Associated
Infections, Atlanta, GA, March 2010. (Oral Presentation)
50. Rogawski E., A.D. Harris, J.K. Johnson, K.A. Thom, E.N. Perencevich, D.J. Morgan.
Transfer of Multidrug-resistant Organisms to Healthcare Worker’s Gloves and Gowns after
Patient Contact Increases with Environmental Contamination. Fifth Decennial International
Conference on Healthcare-Associated Infections, Atlanta, GA, March 2010. (Oral Presentation)
51. Schweizer M.L., K. Alexander, J.P. Furuno, J.K. Johnson, E.N. Perencevich.
Hospital-associated Infection is Associated with Longer Post-infection Length of Stay (LOS)
among Pediatric Patients with S. aureus Bacteremia. Poster Presentation. Fifth Decennial
International Conference on Healthcare-Associated Infections, Atlanta, GA, March 2010.
Page 27
JKJohnson
52. Johnson, J.K., M. Lee, G. Robinson, T. Ranke, R.A. Venezia, J.P. Nataro. Prevalence of
Respiratory Viruses during Influenza Season. 26th Pan American Society of Clinical Virology.
April 2010. Daytona Beach, FL.
53. Johnson, J.K., G. Robinson, M. Lee, T. Ranke, R. A. Venezia. Detection of Acinetobacter
baumannii in Surveillance Cultures. American Society of Microbiology 110th General Meeting.
May 2010. San Diego, CA.
54. Hebden, J, E. Maambo, A.D. Harris, J.K. Johnson. Evaluation of the Two Different
Microbiologic Criteria Applied to Common Skin Contaminants in the National Healthcare Safety
Network Laboratory-Confirmed Blood stream Infection Definition. 50th annual Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2010. Boston,
MA.
55. Ajao, A.O., T. Ranke, G Robinson, M. Lee, J.P. Furuno, A.D. Harris, K.A. Thom, J.K.
Johnson. Detection of Multi-drug resistant Acinetobacter baumannii (MDR-AB) in Peri-rectal
Surveillance Cultures for Critically Ill Patients for Infection Control. 50th annual Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2010. Boston,
MA.
56. Standiford, H., J. Hebden, R.A. Venezia, M. Tripoli, M. Emerick, E. Perencevich, A.D.
Harris, J.K. Johnson. An Extensive Methicillin-Resistant Staphylococcus aureus (MRSA)
Eradication Program at an Academic Medical Center Cost and Effect on Hospital-Acquired
MRSA Bacteremia. 50th annual Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC). September 2010. Boston, MA.
57. Roghmann, M.C., J.K. Johnson, O. C. Stine, A. Lydecker, K. Ryan, A. R. Shuldiner, B. D.
Mitchell. Lack of Familial Aggregation of Persistent Staphylococcus aureus Colonization in Old
Order Amish. 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy
(ICAAC). September 2010. Boston, MA.
58. Roghmann, M.C., A.O. Ajao, A. Lydecker, R.P. Adhikari, H. Karaizi, W.H. Chen, J.K.
Johnson, M.J. Aman. Lower Antibody Levels to Staphylococcus aureus Exotoxins associated
with Sepsis in Hospitalized Patients with Invasive S. aureus Infections. 50th annual Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2010. Boston,
MA. (Oral presentation)
59. Ajao A.O., J.K. Johnson, A.D. Harris, M. Zhan, J.C. McGregor, K.A. Thom, J.P. Furuno.
Risk of acquiring Extended-spectrum-β-lactamase (ESBL) producing Klebsiella pneumoniae and
Escherichia coli from prior room occupants in intensive care unit. Society for Healthcare
Epidemiology of America (SHEA) Annual Meeting, Dallas, Texas, April 2011.
60. Ajao A.O., J.P. Furuno, A.D. Harris, M. Lee, G. Robinson, J.K. Johnson. Prevalence and
Molecular Characterization of Extended-Spectrum-β-lactamase (ESBL) and AmpC β-lactamase
Genes among Klebsiella spp. and Escherichia coli Colonizing Isolates in Intensive Care Unit
Patients. Society for Healthcare Epidemiology of America (SHEA) Annual Meeting, Dallas,
Texas, April 2011.
61. Preas, MA, L. Conway, J. Hebden, G. Robinson, M. Lee, J.K. Johnson, K.A. Thom.
Investigation of a multi-drug resistant Klebsiella pneumoniae outbreak in a Cardiac Surgery
Intensive Care Unit (CSICU). Association for Professionals in Infection Control and
Epidemiology (APIC) 2011 Annual Meeting, Baltimore.
62. Harris-Williams M., K.A. Thom, J.K. Johnson, G. Robinson, J. Hebden. Remaining
Vigilant in Monitoring for Methicillin- Susceptible Staphylococcus aureus (MSSA) in a
Page 28
JKJohnson
Neonatal Intensive Care Unit (NICU). Association for Professionals in Infection Control and
Epidemiology (APIC) 2011 Annual Meeting, Baltimore.
63. Stancil A., J.P. Furuno, O.C. Stine, L. Zhao, A.D. Harris, R.A. Bonomo, J.K. Johnson.
Characterization of Plasmids Among Escherichia coli and Klebsiella spp. Possessing AmpC βlactamases. Interscience Conference on Antimicrobial Agents and Chemotherapy 51st Meeting.
September 2011. Chicago, IL. (Abstract # k-1917)
64. Hazen T.H., D.A. Rasko, L. Zhao, A.D. Harris, J.K. Johnson. Similarity of plasmids
harboring FOX-5 AmpC -lactamases in Escherichia coli and Klebsiella spp. Interscience
Conference on Antimicrobial Agents and Chemotherapy 51st Meeting. September 2011.
Chicago, IL.
65. Johnson J.K., G. Robinson, D.J. Morgan, A.D. Harri and the BUGG Network. Survival of
Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococci
(VRE) for an Extended Period of Transport. Interscience Conference on Antimicrobial Agents
and Chemotherapy 51st Meeting. September 2011. Chicago, IL. (Abstract # K-213)
66. Johnson J.K., K.A. Thom, A.D. Harris, D.J. Morgan, A.O. Ajao, J.P. Furuno. Carbapenem
Resistance in Extended-spectrum Beta-lactamase (ESBL)-producing Klebsiella and Escherichia
coli (ESBL-KE). Interscience Conference on Antimicrobial Agents and Chemotherapy 51st
Meeting. September 2011. Chicago, IL. (Abstract # K-818)
67. Comer A.C., J.K. Johnson, J.M. Hirshon, K.K. Hall, S.L. Moore, J.H. Rosenberg, T.D.
MacKenzie, J.P. Furuno. Development of Nursing Home-specific Antibiograms. 51st Annual
Interscience Conference on Antimicrobial Agents and Chemotherapy. September 2011, Chicago
IL.
68. Strassle P, Thom K, Johnson J.K., Shanholtz C, Mueller K, Lissauer M, Rew C, Raymond
L, Harris AD. Environmental Contamination by Patients with Multidrug-resistant Acinetobacter
baumannii. At the 51th Annual Interscience Conference on Antimicrobial Agents and
Chemotherapy (ICAAC), Chicago, IL, September 2011. (Poster Presentation)
69. Roghmann M.C., J.K. Johnson, E.F. Mongodin. Metagenomic Analysis of Anterior Nares
Colonization in Nursing Home Residents. At the 49th Annual Meeting of the Infectious Diseases
Society of America (IDSA), Boston, MA. October 20-23, 2011. (Poster Presentation)
70. T. Ranke, M. Lee, G. Robinson, T. Karchmer, J.K. Johnson. Polymerase Chain Reaction
(PCR) Based Identification Of VanA And VanB Genes For The Detection Of Vancomycin
Resistant Enterococci (VRE) From Rectal Samples In A Long Term Rehabilitation Hospital.
American Society of Microbiology 112th General Meeting. June 2012. San Francisco, CA.
71. Smith, M.D. B. Turng. A.D. Harris. A.J. Horneman. J.K. Johnson. Mechanisms of
Carbapenem Resistance in Multidrug-Resistant (MDR) Acinetobacter baumannii in Maryland.
American Society of Microbiology 112th General Meeting. June 2012. San Francisco, CA.
72. Johnson, J.K., LE Wilson, L. Zhao, K.A. Thom, A.D. Harris, and Maryland MDRO
Prevention Collaborative. Assessing the Prevalence of Enterobacteriaceae Producing Klebsiella
pneumoniae Carbapenemases (KPC) in Maryland. At the 52th Annual Interscience Conference
on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, September 2012.
(Poster Presentation)
73. McDanel JS, Perencevich E, Diekema DJ, Winokur P, Johnson J.K., Schweizer ML. The
Molecular Epidemiology of Staphylococcus aureus from Patients with Influenza-Like-Illness
(ILI) Who Develop Secondary S. aureus Pneumonia. Poster Presentation. ID Week Conference,
A Joint Meeting of Infectious Diseases Society of America, Society for Healthcare
Page 29
JKJohnson
Epidemiology of America, HIV Medicine Association, and Pediatric Infectious Diseases Society,
San Diego, CA. October 18, 2012.
74. McDanel JS, Perencevich E, Diekema DJ, Storm J, Winokur P, Johnson J.K., Schweizer
ML. The Epidemiology of Patients with Post-Influenza S. aureus Pneumonia. Poster
Presentation. ID Week Conference, A Joint Meeting of Infectious Diseases Society of America,
Society for Healthcare Epidemiology of America, HIV Medicine Association, and Pediatric
Infectious Diseases Society, San Diego, CA. October 19, 2012.
75. Pepin CS, Ranke TD, Harris AD, Pineles L, Morgan DJ, Johnson J.K. The Prevalence of
Carbapenem-Resistant Gram-Negative Gastrointestinal Colonization on Admission and
Discharge in the ICU in 20 Geographically Different Acute Care Centers in the U.S. At the 53rd
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Denver, CO,
September 2013. (Oral Presentation)
76. Heil E, Boutin M, Johnson J.K. Characterizing Ceftaroline and Daptomycin MICs
Compared to Vancomycin MICs in Staphylococcus aureus Blood Culture Isolates at a Large
Academic Medical Center. Interscience Conference on Antimicrobial Agents and Chemotherapy.
Denver, CO. September 2013.
77. Kanack K, Salimnia H, Schreckenberger P, Johnson K., Carroll K, Morgan M, Loeffelholz
M, Jenkins S, Daly J, Richards S, Barrett B, Bouzac K, Lingenfelter B. Clinical Evaluation of a
Multiplex PCR Blood Culture Identification Panel for Simultaneous Detection of Bacteria,
Yeast, and Select Antimicrobial Resistance Genes. Interscience Conference on Antimicrobial
Agents and Chemotherapy. Denver, CO. September 2013.
78. Papp-Wallace KM, Winkler ML, Gatta JA, Taracila MA, Chilakala S, Xu Y, Johnson J.K.,
Bonomo RA. Avibactam (AVI) is a Potent Inhibitor of the CMY-2 β-lactamase and Restores the
Susceptibility of Ceftaxidime (CAZ) Against CMY-Producing E. coli. Interscience Conference
on Antimicrobial Agents and Chemotherapy. Denver, CO. September 2013.
79. Boutin M, Ranke T, Harris H, Thom K, Johnson J.K. Increase in Colonization Prevalence
of Klebsiella pneumoniae Carbapenemase (KPC) producing Enterobacteriaceae in Intensive
Care Units Over a 6-Year Period. Interscience Conference on Antimicrobial Agents and
Chemotherapy. Denver, CO. September 2013.
80. McDanel JS, Perencevich E, Diekema DJ, Winokur P, Johnson J.K., Herwaldt L, Smith T,
Chrischilles E, Dawson J, Schweizer ML. Predictors of Poor Outcomes in Patients with
Methicillin-resistant Staphylococcus aureus (MRSA) Pneumonia. ID Week Conference, A Joint
Meeting of Infectious Diseases Society of America, Society for Healthcare Epidemiology of
America, HIV Medicine Association, and Pediatric Infectious Diseases Society, San Diego, CA.
October 2, 2013.
81. Boutin M, Thom K, Zhan M, Johnson J.K. A novel agent to decrease contamination on
hospital scrubs. ID Week Conference, A Joint Meeting of Infectious Diseases Society of
America, Society for Healthcare Epidemiology of America, HIV Medicine Association, and
Pediatric Infectious Diseases Society, San Diego, CA. October 2, 2013.
82. Cifra CL, Johnson J.K., Custer JW. Invasive Community-Associated MRSA Infection
Presentation as a Lemierre-like Syndrome in an Adolescent Boy. 20th Pediatric Critical Care
Colloquium. Washington DC. November 2-5, 2013.
83. Bork JT, Heil E, Leekha S, Johnson J.K. Impact of CLSI Guideline 2014 Changes on the
Reporting of Cefepime Susceptibility for Enterobacteriaceae at ICAAC 2014, Washington DC,
September 7, 2014. (Poster)
Page 30
JKJohnson
84. Heil E, Leekha S, Bork JT, Johnson J.K. Impact of CLSI Enterobacteriaceae Breakpoint
Changes on Antibiotic Use at a Large Academic Medical Center at ICAAC 2014, Washington
DC, September 7, 2014. (Poster)
85. Roghmann M, Johnson J.K., Sorkin J, Langenberg P, Sorace B and Mody L. Methicillinresistant S. aureus (MRSA) and Methicillin-susceptible S. aureus (MSSA) Transmission to the
Gowns and Gloves of Health Care Workers interacting with Long Term Care Residents at ID
Week 2014, Philadelphia PA, October 9, 2014. (Poster)
86. Rock C, Harris AD, Johnson J.K., Bischoff W, Thom K. Infrequent Air Contamination
with Acinetobacter baumannii Surrounding Known Colonized/Infected patients at ID Week
2014, Philadelphia PA, October 9, 2014. (Poster)
87. Bork JT, Heil E, Leekha S, Badamas R, Johnson J.K.. Rapid Testing using Verigene
Microarray in Combination with Antimicrobial Stewardship Intervention in Gram-negative
Bacteremia at ID Week 2014, Philadelphia PA, October 9, 2014. (Poster)
88. Epstien, L, Laufer AS, Preas MA, Harris AD, Johnson J.K., Blythe D, Edwards JR, Gould
CV, Leekha S. Successful Interventions to Reduce Unnecessary Urine Cultures in Intensive Care
Units at a Tertiary Care Hospital, Baltimore, MD, 2011-2013 at ID Week 2014, Philadelphia PA,
October 10, 2014. (Oral)
89. Al-Salamah T, Hines MC, Hayes B, Heil E, Witting M, Johnson J.K., Winters M, Gaasch
W, Mallemat. Antibiogram does not predict Escherichia coli resistance to ciprofloxacin in
women presenting with uncomplicated urinary tract infection to an urban, academic medical
center emergency department: a prospective, observational study [Abstract program #254]. 2014
American College of Emergency Physicians Scientific Assembly. Chicago, IL. Ann Emerg Med
2014;64(4 Supplement):S91.
90. Johnson, J.K., G Robinson, N Karikari, L Zhao, T Wagener, T Walker. The Acuitas MDRO
Gene Test Compared to Culture/Molecular Assay for Detection of Gene Families Associated
with Multidrug-Resistant Organisms from Single Peri-anal Swabs for Surveillance. ECCMID.
April 2015. Denmark.
91. Lascols, C, SC Bonaparte, DR Lonsway, J.K. Johnson, G Robinson, JK Rasheed, BM
Limbago. Snapshot of Antimicrobial Resistance in Enterobacteriaceae in the United States.
ECCMID. April 2015. Denmark.
92. Morgan DJ, CAD Burnham, L Pineles, J.K. Johnson, AD Harris, E Dubberke. The
frequency of Clostridium difficile colonization and transmission in an intensive care unti (ICU).
Society of Hospital Epidemiology (SHEA) Spring 2015. May 14-17 in Orlando, Florida. Poster
7137.
93. MC Roghmann, J.K. Johnson, JD Sorkin, P Langenberg, A Lydecker, B Sorace, L Levy, L
Mody. Transmission of MRSA to Healthcare Personnel Gowns and Gloves During Care of
Nursing Home Residents. Society of Hospital Epidemiology (SHEA) Spring 2015. May 14-17 in
Orlando, Florida. Oral 7125.
94. Doll M, MA Preas, C Mitchell, L Wilson, C Carothers, J.K. Johnson, S Leekha. Pseudooutbreak of Aspergillosis at a Tertiary Care Hospital. Society of Hospital Epidemiology (SHEA)
Spring 2015. May 14-17 in Orlando, Florida.
95. Robinson, G, N Karikari, T Wagner, T Walker, J.K. Johnson. The Detection of
Carbapenemases in Carbapenem-Resistant Gram-Negative Bacteria from an Academic Medical
Center. American Society of Microbiology 115th General Meeting. May 2015. New Orleans,
LA. Poster 1067.
Page 31
JKJohnson
96. A Demogines, S. Fouch, JM Balada-Llasat, K Everhart, A Leber, T Barney, JA Daly, T
Burger, P Lephart, S. Desjarlais, P Schreckenberger, C Rells, SL Reed, L LeBlanc, KC Chapin,
J.K. Johnson, JA Miller, KC Carroll, J Mestas, J Dien Bard, T Enomoto, MJ Bankowski, K
Holmberg, KM Bourzac. Multi-Center Clinical Evaluation of a Multiplex
Meningitis/Encephalitis PCR Panel for Simultaneous Detection of Bacteria, Yeast, and Viruses
in Cerebrospinal Fluid Specimens. American Society of Microbiology 115th General Meeting.
May 2015. New Orleans, LA. Poster 1074.
97. MC Roghmann, J.K. Johnson, JD Sorkin, P Langenberg, A Lydecker, B Sorace, L Levy, L
Mody. Transmission of MRSA to Healthcare Personnel Gowns and Gloves During Care of
Nursing Home Residents. American Geriatric Society (AGS) Annual Meeting. May 15-17, 2015
in National Harbor, Maryland. Poster B167, chosen for the Presidential Poster Session.
98. Pineles L, Morgan DJ, Johnson J.K., Sorkin J, Langenberg P, Lydecker A, Lesse A, Sellick
J, Gupta K, Leykum L, Lepcha N, Roghmann MC. Gown and glove use to prevent the spread of
MRSA in VA Community Living Centers (CLCs). Poster presented at ID Week, October 2015,
San Diego, CA.
99. J.K. Johnson, V Albrecht, M Karlsson, GL Robinson, V Stevens, B Werner, A Schuetz, D
Wolk, EM Marlowe, E Babady, M Miller, K Culbreath, S Butler-Wu, D Diekema, JK Rasheed,
B Limbago. Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in US Clinical
Laboratories. ASM Microbe 2016 Meeting on June 20, 2016 in Boston, MA.
100. H Poonawala, K Saharia, S Medino-Moreno, M Filippell, JK Johnson, S Leekha, RR
Redfield. Use of a Single Xpert MTB/RIF Assay to Determine Duration of Airborne Isolation in
Hospitalized Patients Suspected of Pulmonary Tuberculosis. ID-Week. October 26-20, 2016
New Orleans, LA. (poster accepted)
Published Multimedia
1. Nataro, JP, I Stephens, J.K. Johnson. Molecular Diagnosis of Infectious Diseases.
Critical Conversations with Pediatric Experts. November 2010. 5(11) Interviewed, “New
Test for Detecting Specific Flu Viruses”. Pediatric Press Fall 2010/Winter 2011 University of
Maryland Hospital for Children, University of Maryland Medical Center.
2. Interviewed. A Quicker Test for Deadly Viruses in the Very Young. The Baltimore Sun.
Monday October 18, 2010. Pages 1 and 5.
3. Interviewed. WJZ TV. Monday October, 18, 2010. News at 5 p.m., 6 p.m., and 11 p.m.
4. Johnson, JK. “A Case of Mistaken Identity” ASM Clinical Microbiology Mentoring
Committee Case Report.
2015.
http://clinmicro.asm.org/index.php/explore-theprofession/what-is-clinical-microbiology/418-clinical-microbiology-case-studies-clinicalmicrobiology-case-studies
Major Invited Speeches
Local
1.
Johnson, J.K., “Epidemiology of Antibiotic Resistant Gram Negative Organisms.”
Medical Technology Research Seminar, Department of Medical Research and
Technology, University of Maryland School of Medicine, Baltimore, Maryland, 2009.
2.
Johnson, J.K., “Multi-drug Resistant Gram Negative Microorganisms (MDRO)”
University of Maryland Medical Center, Laboratories of Pathology, Baltimore, Maryland,
2011.
Page 32
JKJohnson
3.
4.
5.
6.
7.
8.
9.
10.
Johnson, J.K. “Career Options: Director of a Clinical Microbiology Laboratory”
American Society of Microbiology, Maryland Branch on May 3, 2012.
Johnson, J.K. “Carbapenem-Resistant Enterobacteriaceae (CREs): The New Superbug.
What are they and how to the affect your antimicrobial options.” Department of Medicine
Grand Rounds, Maryland General Hospital, Baltimore, Maryland on May 9, 2013.
Keynote Address at Pre-commencement ceremony. Department of Medical and Research
Technology at the University of Maryland, Baltimore on May 17, 2012.
Johnson, J.K. “Carbapenem-Resistant Enterobacteriaceae (CREs): The New Superbug.”
Clinical Didactic Conference. Department of Medical and Research Technology
University of Maryland School of Medicine, Baltimore, Maryland on May 30, 2013.
Johnson, J.K. “Detecting Drug Resistance in Gram-negative Bacteria” Novel Aspects in
Biomedical Sciences Series, Department of Medical and Research Technology University
of Maryland School of Medicine, Baltimore, Maryland on September 24, 2013.
Johnson, J.K. “Multidrug-Resistant Organisms (MDROs): The Gram Negative
Perspective” New Molecular Screening Solutions for Multi-Drug Resistant Organisms,
OpGen, November 22, 2013.
Johnson, J.K. “Transmission of Emerging Plasmid-mediated β-lactamases in Multi-drug
Resistant Gram-negative Bacteria” Department of Microbiology and Immunology
Seminar, University of Maryland School of Medicine, Baltimore, Maryland on March 5,
2014.
Johnson, J.K. “Transmission of Multi-drug Resistant Gram-negative Bacteria” Mesoscale
Diagnostics, Rockville, Maryland on April 23, 2014.
National
1.
Johnson, J.K. “Antibiotic Resistance in Gram Negative Bacteria – Focus on βlactamases,” 24th Annual Maryland Clinical Microbiology Meeting, Annapolis, Maryland
2007.
2.
Johnson, J.K. “Impact of Rapid C. albicans, S. aureus, and Enterococcus Results on
Patient Care” Educational Seminar, 107th American Society of Microbiology General
Meeting, Toronto, Ontario, Canada, 2007.
3.
Johnson, J.K., “The Role of the Microbiologist in Infection Control” 11th Annual
Infectious Disease Fellows Course on Infectious Diseases, Johns Hopkins University,
Baltimore, Maryland, 2007.
4.
Johnson, J.K. “Rapid and Real-time Rapid Diagnostic from Positive Blood Cultures: The
UMMC Experience” Northeastern Ohio Association of Clinical Microbiologists,
Cleveland, Ohio, 2008.
5.
Johnson, J.K., “Carbapenem-Resistant Enterobacteriaceae (CREs): The New Superbug.”
Department of Medicine Grand Rounds, Geisinger Medical Center, Danville,
Pennsylvania on September 6, 2013.
6.
Johnson, J.K. “Multi-drug Resistant Organisms (MDROs): The Threat We Face.” ASM
Satellite Symposium. 114th General Meeting American Society of Microbiology. Boston,
Massachusetts. May 19, 2014.
Page 33
JKJohnson
7.
8.
9.
10.
11.
Johnson, J.K., “The Role of the Microbiologist in Infection Control and Hospital
Epidemiology” at the 18th Annual Infectious Disease Fellows Course on Infectious
Diseases at Johns Hopkins University on July 8, 2014 in Baltimore, Maryland.
Johnson, JK. “The Impact of Rapid Molecular Analysis of Positive Blood Cultures:
Discovering the antimicrobial Stewardship Dream Team” at the Pathology Grand Rounds
at Cornell-Weill Medical College on April 1, 2015.
“What to Report to Clinicians to Reduce Unnecessary Treatment-Explaining Clinical
Microbiology Reports/Providing Limited Information.” at the 115th General Meeting of
the American Society of Microbiology in the Diagnostic Microbiology and Epidemiology
Symposium, Session Titled Overuse and Overdiagnosis in Clinical Microbiology on June
1, 2015 in New Orleans, LA.
Johnson, J.K. “Guess the Resistance Mechanism-Case 1” at the ASM Microbe 2016
Meeting of the American Society of Microbiology in the Clinical Science and
Epidemiology Symposium, Session Titled Guess the Resistance Mechanism on June 18,
2016 in Boston, MA.
Johnson, J.K. “Guess the Resistance Mechanism-Case 2” at the ASM Microbe 2016
Meeting of the American Society of Microbiology in the Clinical Science and
Epidemiology Symposium, Session Titled Guess the Resistance Mechanism on June 18,
2016 in Boston, MA
International
1.
Johnson, J.K. “Healthcare Associated Infections (HAIs): The Role of the Microbiology
Laboratory.” Puerto Rico Society of Microbiologist and Puerto Rico ASM Branch SemiAnnual Meeting New Trends and Diagnostic Challenges in Healthcare Associated
Infections (HAIs), Guaynabo, Puerto Rico on January 25, 2014.
Page 34